http://www.pharmajournalist.com/catalent-to-acquire-gene-therapy-leader-paragon-bioservices-inc-for-1-2-billion/ 2019-04-19T10:09:54+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Catalent-Logo.png http://www.pharmajournalist.com/enesi-pharma-and-barda-drive-enter-public-private-partnership-to-develop-implavax-solid-dose-vaccine-delivery-technology-against-influenza/ 2019-04-19T10:12:43+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/Enesi-Pharma-Logo.jpg http://www.pharmajournalist.com/sutter-health-upmc-and-dnanexus-initiate-collaboration-to-improve-personalized-treatments-for-people-with-multiple-sclerosis/ 2019-04-19T10:16:39+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/DNAnexus-logo.png http://www.pharmajournalist.com/bristol-myers-squibb-shareholders-approve-celgene-acquisition/ 2019-04-19T10:18:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/puretech-health-announces-collaboration-with-boehringer-ingelheim/ 2019-04-19T10:22:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/sk-biopharmaceuticals-and-twoxar-sign-collaboration-agreement-to-discover-and-develop-first-in-class-treatments-for-non-small-cell-lung-cancer/ 2019-04-19T10:26:18+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/SK-Biopharmaceuticals-and-twoXAR.jpg http://www.pharmajournalist.com/wp-content/uploads/2019/04/SK-Biopharmaceuticals-and-twoXAR.jpg http://www.pharmajournalist.com/recro-pharma-announces-six-year-extension-of-license-and-supply-agreement-between-teva-and-recro-gainesville/ 2019-04-19T10:29:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/ms-pharma-announces-acquisition-of-genepharm/ 2019-04-19T10:32:51+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/MS-Pharma.jpg http://www.pharmajournalist.com/wp-content/uploads/2019/04/MS-Pharma.jpg http://www.pharmajournalist.com/allele-biotechnology-and-scm-lifescience-sign-a-joint-research-and-development-agreement-to-develop-ipsc-based-diabetes-treatment/ 2019-04-19T10:34:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/dr-reddys-laboratories-announces-acquisition-of-anda-portfolio/ 2019-04-19T10:37:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/dr-reddy-logo.png http://www.pharmajournalist.com/casi-pharma-in-licenses-exclusive-worldwide-rights-to-novel-anti-cd38-monoclonal-antibody-program-from-black-belt-therapeutics/ 2019-04-19T10:40:41+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/casi-pharmaceuticals-logo.png http://www.pharmajournalist.com/dndi-and-atomwise-collaborate-to-advance-drug-development-using-ai-for-neglected-diseases/ 2019-04-19T10:50:59+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/DNDi-LOgo.png http://www.pharmajournalist.com/alnylam-initiates-illuminate-b-phase-3-pediatric-study-of-lumasiran-to-treat-primary-hyperoxaluria-type-1/ 2019-04-19T10:53:36+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/alnylam-pharmaceuticals_logo.jpg http://www.pharmajournalist.com/novartis-announces-fda-filing-acceptance-and-priority-review-of-brolucizumab-rth258-for-patients-with-wet-amd/ 2019-04-19T10:57:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/stc-biologics-becomes-the-largest-biologics-cdmo-within-five-miles-of-cambridge-ma-after-addition-of-its-new-gmp-manufacturing-facility/ 2019-04-19T11:03:57+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/STC-Site-LOGO.png http://www.pharmajournalist.com/greenfield-global-inc-to-establish-european-manufacturing-facility-in-ireland/ 2019-04-19T11:06:23+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/Greenfield-Global-Logo.png http://www.pharmajournalist.com/adare-acquires-egalets-proprietary-parvulet-technology-platform/ 2019-04-19T11:09:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/i-mab-biopharma-and-wuxi-biologics-announce-long-term-strategic-manufacturing-partnership-for-five-clinical-and-one-commercial-programs/ 2019-04-19T11:11:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/fibrocell-announces-collaboration-with-castle-creek-pharmaceuticals-to-develop-and-commercialize-fcx-007-gene-therapy/ 2019-04-19T11:13:59+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/Fibrocell-Logo.png http://www.pharmajournalist.com/why-is-it-critical-to-embed-lifecycle-management-in-your-combination-products-development/ 2019-04-23T15:33:36+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/CPLM-Summit-Banner-Pharma-Journalist.png http://www.pharmajournalist.com/7th-annual-predict-tumor-models-boston-pharma-and-biotechs-advance-their-tumor-model-utilization-to-accelerate-oncology-developments/ 2019-04-24T11:59:56+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/PREDiCT_Tumor-Models-Boston-Logo.jpg http://www.pharmajournalist.com/highly-potent-apis-2019-conference-interview-with-bayer-pharma/ 2019-04-25T08:35:59+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/HAPAPI-Banner-SMi-Pharma-Journalist.jpg http://www.pharmajournalist.com/biotheque-wallonie-bruxelles-bwb-to-lead-a-workshop-on-reinvigorate-your-through-data-quality-enhancement-and-financial-and-economic-tools-during-the-9th-annual-b/ 2019-04-25T09:36:06+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/Biobanking-Banner-SMi_Pharma-Journalist.jpg http://www.pharmajournalist.com/hear-from-amgen-speaking-at-smis-4th-annual-conference-and-exhibition-pre-filled-syringes-west-coast-2019/ 2019-04-25T09:43:04+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Pre-Filled-Syringes-West-Coast_Pharma-Journalist.jpg http://www.pharmajournalist.com/la-jolla-pharmaceutical-company-announces-fdas-grant-of-breakthrough-therapy-designation-for-ljpc-0118-for-the-treatment-of-severe-malaria/ 2019-04-26T06:00:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/fsd-pharma-to-acquire-prismic-pharmaceuticals/ 2019-04-26T06:02:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/forge-and-basilea-enter-into-multi-target-agreement-to-discover-and-develop-novel-antibiotics/ 2019-04-26T06:03:52+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/Basilea.jpg http://www.pharmajournalist.com/adc-therapeutics-and-adagene-announce-license-agreement/ 2019-04-26T06:05:21+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/ADC_Therapeutics_Logo.png http://www.pharmajournalist.com/teva-announces-launch-of-a-generic-version-of-vesicare-solifenacin-succinate-tablets-in-the-united-states/ 2019-04-26T06:06:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/TEVA-Pharma.jpg http://www.pharmajournalist.com/teva-announces-update-on-fremanezumab-clinical-development-for-use-in-episodic-cluster-headache/ 2019-04-26T06:08:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/TEVA-Pharma.jpg http://www.pharmajournalist.com/abbvie-expands-immunology-portfolio-in-the-u-s-with-fda-approval-of-skyrizi-risankizumab-rzaa-for-moderate-to-severe-plaque-psoriasis/ 2019-04-26T06:10:42+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/fulcrum-therapeutics-acquires-global-rights-to-losmapimod-a-potential-disease-modifying-therapy-for-facioscapulohumeral-muscular-dystrophy/ 2019-04-26T06:13:17+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/fulcrum-Therapeutics-Logo.png http://www.pharmajournalist.com/ipsen-completes-acquisition-of-clementia-pharmaceuticals/ 2019-04-26T06:18:45+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Ipsen-Group-Image.jpg http://www.pharmajournalist.com/salix-enters-into-exclusive-license-agreement-with-mitsubishi-tanabe-pharma/ 2019-04-26T06:23:55+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/Salix-Pharma-Logo.png http://www.pharmajournalist.com/urogen-pharma-announces-early-stage-feasibility-agreement-with-janssen/ 2019-04-26T06:26:41+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/UroGen-Pharma-Logo.jpg http://www.pharmajournalist.com/lilly-and-avidity-biosciences-announce-licensing-and-research-collaboration/ 2019-04-26T06:28:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/elpiscience-and-bio-techne-announce-strategic-collaboration/ 2019-04-26T06:29:33+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Bio-Techne-Logo.jpg http://www.pharmajournalist.com/oakrum-pharma-and-biophore-announce-product-development-and-commercialization-partnership/ 2019-04-26T06:31:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/drug.jpg http://www.pharmajournalist.com/tb-alliance-and-mylan-announce-global-collaboration/ 2019-04-26T06:33:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/mylan-1.jpg http://www.pharmajournalist.com/knopp-biosciences-receives-fda-orphan-drug-designation-for-dexpramipexole-for-treatment-of-hypereosinophilic-syndrome/ 2019-04-26T06:37:35+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/Knopp-Biosciences-Logo.png http://www.pharmajournalist.com/fda-approves-pembrolizumab-plus-axitinib-for-advanced-renal-cell-carcinoma/ 2019-04-26T06:40:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/pfizer-and-lilly-announce-top-line-results-from-long-term-phase-3-study-of-tanezumab-in-patients-with-osteoarthritis/ 2019-04-26T06:45:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/acadia-pharma-initiates-phase-3-clarity-program-with-pimavanserin-as-adjunctive-treatment-for-major-depressive-disorder/ 2019-04-26T06:52:44+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/ACADIA-Pharma-Logo.jpg http://www.pharmajournalist.com/gilead-announces-topline-data-from-phase-3-stellar-3-study-of-selonsertib-in-bridging-fibrosis-f3-due-to-nash/ 2019-04-26T06:54:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/forbius-first-patient-dosed-in-a-phase-1b-myelofibrosis-trial-of-avid200-a-novel-tgf-beta-1-3-inhibitor/ 2019-04-26T06:57:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/velabs-therapeutics-to-cooperate-with-chiome-bioscience-in-the-field-of-gpcr-specific-functional-antibody-screening/ 2019-04-26T07:14:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/02/abzena-clinical.jpg http://www.pharmajournalist.com/lonzas-fully-automated-plate-based-robotic-solution-enables-simple-fast-and-reliable-endotoxin-detection/ 2019-04-26T07:19:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/lonza.jpg http://www.pharmajournalist.com/less-than-2-weeks-until-smis-19th-annual-pain-therapeutics-conference-in-london/ 2019-04-30T08:49:07+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/PainTherapeutics_Banner_Pharma-Journalist.jpg http://www.pharmajournalist.com/only-two-weeks-left-until-the-2nd-injectable-drug-delivery-conference-in-london/ 2019-04-30T09:33:58+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/Injectable-Drug-Delivery-2019_Pharma-Journalist.jpg http://www.pharmajournalist.com/abbott-laboratories-to-lead-panel-discussion-with-eli-lilly-and-medimmune-at-smis-4th-annual-prefilled-syringes-west-coast-conference/ 2019-04-30T09:43:07+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Pre-Filled-Syringes-West-Coast_Pharma-Journalist.jpg http://www.pharmajournalist.com/biopharma-process-systems-nibsc-to-lead-interactive-workshops-for-the-lyophilisation-conference-2019/ 2019-05-01T14:49:36+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/300x250-1.jpg http://www.pharmajournalist.com/fda-approves-praluent-alirocumab-to-prevent-heart-attack-stroke-and-unstable-angina-requiring-hospitalization/ 2019-05-03T08:30:36+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/zynquistatm-now-approved-in-the-european-union-for-treatment-of-adults-with-type-1-diabetes/ 2019-05-03T08:37:10+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/takeda-opens-new-global-research-center-in-san-diego/ 2019-05-03T08:38:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/sandoz-enters-agreement-for-proposed-trastuzumab-biosimilar-currently-in-phase-iii-development-to-treat-selected-her2-positive-cancer-tumors/ 2019-05-03T08:58:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/sandoz.jpg http://www.pharmajournalist.com/astrazeneca-starts-artificial-intelligence-collaboration-to-accelerate-drug-discovery/ 2019-05-03T09:00:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/polyprox-therapeutics-raises-3-4m-seed-financing-to-validate-novel-class-of-drugs-to-treat-cancer/ 2019-05-03T09:03:55+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/polyprox-logo.png http://www.pharmajournalist.com/gsk-receives-us-approval-of-benlysta-for-intravenous-use-in-children-with-lupus-aged-five-years-and-above/ 2019-05-03T09:06:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/lynparza-receives-positive-eu-chmp-opinion-for-1st-line-maintenance-treatment-of-brca-mutated-advanced-ovarian-cancer/ 2019-05-03T09:10:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/amgen-and-syapse-enter-precision-medicine-collaboration-in-oncology/ 2019-05-03T09:12:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg http://www.pharmajournalist.com/cstone-and-numab-announce-exclusive-regional-licensing-agreement-for-nd021/ 2019-05-03T09:15:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/tmunity-and-uc-san-francisco-announce-exclusive-license-and-research-collaboration-to-advance-tcr-t-cell-therapies-for-pediatric-cancers/ 2019-05-03T09:19:07+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/Tmunity-Logo.png http://www.pharmajournalist.com/canopy-biosciences-acquires-zellkraftwerk-gmbh/ 2019-05-03T09:22:33+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/Canopy-Biosciences-Logo.jpg http://www.pharmajournalist.com/eirgenix-enters-into-global-license-agreement-for-the-commercialization-of-its-biosimilar-drug-eg12014/ 2019-05-03T09:24:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/cardinal-health-specialty-solutions-strengthens-cell-and-gene-therapy-offering-with-pantherx-specialty-pharmacy-collaboration/ 2019-05-03T09:27:28+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/Cardinal-Health-Logo.png http://www.pharmajournalist.com/amal-therapeutics-enters-clinical-collaboration-with-boehringer-ingelheim-to-evaluate-atp128-in-combination-with-bi754091/ 2019-05-03T09:34:02+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/sartorius-stedim-biotech-launches-new-ambr-15-cell-culture-microbioreactor-system/ 2019-05-03T09:45:11+00:00 http://www.pharmajournalist.com/wp-content/uploads/2019/05/ambr-15-cell-culture.jpg http://www.pharmajournalist.com/implandata-successfully-gains-ce-mark-for-its-eyemate-system-for-an-orphan-eye-indication/ 2019-05-03T09:47:16+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/Logo-IOP.png http://www.pharmajournalist.com/samsung-biologics-signed-cdocontract-development-organization-contract-with-gi-innovation/ 2019-05-03T09:49:18+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/Samsung-BioLogics-signed-CDO.jpg http://www.pharmajournalist.com/wp-content/uploads/2019/05/Samsung-BioLogics-signed-CDO.jpg http://www.pharmajournalist.com/glenmark-expands-specialty-portfolio-with-otiprio-co-promotion-agreement-in-the-u-s-with-otonomy-for-acute-otitis-externa-indication/ 2019-05-03T09:53:37+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Glenmark-Pharma-Image.jpg http://www.pharmajournalist.com/abbott-receives-who-prequalification-approval-for-breakthrough-hiv-point-of-care-test/ 2019-05-03T09:55:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Abbott1.png http://www.pharmajournalist.com/first-fda-approved-vaccine-for-the-prevention-of-dengue-disease-in-endemic-regions/ 2019-05-03T09:56:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/exelixis-initiates-phase-3-trial-of-cabozantinib-in-advanced-renal-cell-carcinoma/ 2019-05-03T10:06:00+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Exelixis.jpg http://www.pharmajournalist.com/registration-opens-for-smis-9th-annual-orphan-drugs-rare-diseases-conference/ 2019-05-09T10:25:50+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/300x250-P-300-.jpg http://www.pharmajournalist.com/3-exclusive-speaker-interviews-released-for-pharma-microbiology-west-coast-conference/ 2019-05-09T13:57:31+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/Pharma-Micro-WC_Banner_Pharma-Journalist.jpg http://www.pharmajournalist.com/pfizer-opens-new-state-of-the-art-biologics-clinical-manufacturing-facility-in-andover-massachusetts/ 2019-05-10T07:13:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/pfizer-acquires-clinical-stage-biotech-therachon/ 2019-05-10T07:15:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/ec-approves-lorviqua-lorlatinib-for-certain-adult-patients-with-previously-treated-alk-positive-advanced-non-small-cell-lung-cancer/ 2019-05-10T07:17:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/dupixent-dupilumab-approved-for-severe-asthma-by-european-commission/ 2019-05-10T07:19:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/sanofi.jpg http://www.pharmajournalist.com/verve-therapeutics-founded-to-protect-against-heart-disease-launches-with-58-5-million-in-series-a-funding-led-by-gv/ 2019-05-10T07:22:13+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/Sekar-Kathiresan-Verve.jpg https://pharmajournalist.com/wp-content/uploads/2019/05/Sekar-Kathiresan-Verve.jpg http://www.pharmajournalist.com/fda-approves-first-treatment-for-children-with-lems-a-rare-autoimmune-disorder/ 2019-05-10T07:24:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/bicycle-therapeutics-enters-neuroscience-arena-through-collaboration-with-dementia-discovery-fund/ 2019-05-10T07:25:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/Bicycle-Therapeutics.jpg http://www.pharmajournalist.com/skyhawk-therapeutics-announces-agreement-with-takeda-to-develop-novel-small-molecule-rna-splicing-modifiers-for-neurodegenerative-diseases/ 2019-05-10T07:29:40+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/skyhawk_therapeutics_logo.png http://www.pharmajournalist.com/fda-approves-new-treatments-for-heart-disease-caused-by-a-serious-rare-disease-transthyretin-mediated-amyloidosis/ 2019-05-10T07:31:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/bayer-invests-150-million-to-build-new-cell-culture-technology-center-in-berkeley-to-spur-innovation-of-biotech-therapies/ 2019-05-10T07:33:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/bayer.jpg http://www.pharmajournalist.com/adimab-expands-research-agreement-with-regeneron/ 2019-05-10T07:34:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/regeneron.jpg http://www.pharmajournalist.com/mercks-belsomra-c-iv-meets-primary-efficacy-endpoint-in-phase-3-trial/ 2019-05-10T07:39:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/xencor-doses-first-patient-in-phase-1-study-of-xmab23104-for-the-treatment-of-patients-with-advanced-solid-tumors/ 2019-05-10T07:42:07+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Xencor_Logo.png http://www.pharmajournalist.com/ligand-acquires-milestone-and-royalty-rights-to-sb206-from-novan/ 2019-05-10T07:44:12+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Ligand-Pharmaceuticals-logo.png http://www.pharmajournalist.com/teva-announces-launch-of-a-generic-version-of-tarceva-erlotinib-tablets-in-the-united-states/ 2019-05-10T07:50:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/TEVA-Pharma.jpg http://www.pharmajournalist.com/biontech-acquires-mabvax-therapeutics-antibody-assets-to-expand-portfolio/ 2019-05-10T07:53:44+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/BioNTech.jpg http://www.pharmajournalist.com/sensei-biotherapeutics-announces-clinical-trial-collaboration-agreement-with-astrazeneca-for-two-phase-2-studies-of-sns-301/ 2019-05-10T08:03:19+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/sensei-therapeutics-logo.png http://www.pharmajournalist.com/sartorius-stedim-biotech-introduces-new-simca-16-software-for-multivariate-data-analytics/ 2019-05-10T08:06:51+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/SIMCA_16_BCC_multiplot.png https://pharmajournalist.com/wp-content/uploads/2019/05/SIMCA_16_BCC_multiplot.png http://www.pharmajournalist.com/wise-enrols-first-patient-in-pivotal-clinical-study-of-novel-neuro-electrodes-for-brain-monitoring/ 2019-05-10T08:09:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/02/abzena-clinical.jpg http://www.pharmajournalist.com/recipharm-launches-recipharm-inhalation-solutions-as-its-end-to-end-offering-for-inhalation-products/ 2019-05-10T08:10:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/recipharm.jpg http://www.pharmajournalist.com/c3j-and-ampliphi-announce-successful-completion-of-merger-and-formation-of-bacteriophage-company-armata/ 2019-05-10T08:14:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/novartis-presents-first-of-its-kind-algorithm-based-tool-to-help-ms-patients-and-physicians/ 2019-05-10T09:19:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/akcea-and-ionis-announce-approval-of-waylivra-volanesorsen-in-the-european-union/ 2019-05-10T09:26:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/ionis-pharma1.jpg http://www.pharmajournalist.com/4th-european-prefilled-syringes-summit/ 2019-05-13T09:11:29+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/PPFe4-300x250-copy.jpg http://www.pharmajournalist.com/wp-content/uploads/2019/05/aci.jpg http://www.pharmajournalist.com/smis-lyophilisation-2019-conference-interview-with-geoff-smith/ 2019-05-13T12:02:51+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/300x250-1.jpg http://www.pharmajournalist.com/michel-mikhail-invites-biosimilar-experts-to-attend-smis-10th-annual-biosimilars-conference/ 2019-05-14T10:42:03+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/P-298-Biosimilars-300x250.jpg http://www.pharmajournalist.com/registration-opens-for-inaugural-hpapi-usa-conference-in-october/ 2019-05-14T11:16:47+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/300x250-copy.jpg http://www.pharmajournalist.com/dr-delma-l-broussard-to-speak-at-smis-4th-annual-prefilled-syringes-west-coast-conference-this-june/ 2019-05-16T11:02:53+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Pre-Filled-Syringes-West-Coast_Pharma-Journalist.jpg http://www.pharmajournalist.com/vertex-and-kymera-establish-strategic-collaboration-to-discover-and-develop-targeted-protein-degradation-medicines-for-serious-diseases/ 2019-05-17T09:42:40+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Vertex.jpg http://www.pharmajournalist.com/celgene-announces-pomalyst-granted-breakthrough-therapy-designation-from-fda-for-hiv-positive-and-negative-kaposi-sarcoma/ 2019-05-17T09:44:34+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/celgene-corporation.jpg http://www.pharmajournalist.com/abbvie-resolves-humira-adalimumab-u-s-patent-litigation-with-boehringer-ingelheim/ 2019-05-17T09:45:55+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/takeda-and-frazier-healthcare-partners-announce-collaboration-to-launch-phathom-pharmaceuticals/ 2019-05-17T09:48:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/regenerx-partner-receives-patent-for-new-ophthalmic-formulation-of-thymosin-beta-4/ 2019-05-17T09:50:19+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/RegeneRx-Logo.jpg http://www.pharmajournalist.com/intec-pharma-announces-research-collaboration-agreement-with-merck/ 2019-05-17T09:52:55+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/cumberland-pharmaceuticals-signs-exclusive-licensing-agreement-for-distribution-in-china/ 2019-05-17T09:55:42+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/Cumberland-Pharmaceuticals-Logo.jpg http://www.pharmajournalist.com/hoth-therapeutics-signs-term-sheet-with-zylo-therapeutics-to-acquire-a-license-and-jointly-develop-a-product-to-treat-lupus/ 2019-05-17T09:57:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/zymeworks-enters-its-first-zymelink-antibody-drug-conjugate-platform-licensing-agreement-with-iconic-therapeutics/ 2019-05-17T09:59:28+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/ZymeWorks-Logo.png http://www.pharmajournalist.com/agreement-reached-for-essa-pharma-to-acquire-realm-therapeutics/ 2019-05-17T10:01:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/roche-announces-fda-approval-for-venclexta-plus-gazyva-for-people-with-previously-untreated-chronic-lymphocytic-leukaemia/ 2019-05-17T10:03:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/elevatebio-launches-to-create-and-operate-a-portfolio-of-highly-innovative-cell-and-gene-therapy-companies/ 2019-05-17T10:05:43+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/BaseCamp_1.jpg https://pharmajournalist.com/wp-content/uploads/2019/05/BaseCamp_1.jpg http://www.pharmajournalist.com/exelixis-collaborator-daiichi-sankyo-launches-minnebro-esaxerenone-tablets-in-japan/ 2019-05-17T10:07:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/Daiichi-Pharma.jpg http://www.pharmajournalist.com/lonza-chooses-synpromics-novel-inducible-promoter-platform-to-manufacture-biopharmaceuticals/ 2019-05-17T10:12:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/lonza.jpg http://www.pharmajournalist.com/thermo-fisher-scientific-to-acquire-manufacturing-site-in-cork-ireland-from-gsk/ 2019-05-17T10:15:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/thermo-fisher-scientific.jpg http://www.pharmajournalist.com/civica-rx-and-xellia-pharmaceuticals-join-forces-to-reduce-chronic-drug-shortages/ 2019-05-17T10:17:24+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/Martin_VanTrieste_of_Civica_and_Carl-Aake_Carlsson_of_Xellia.jpg http://www.pharmajournalist.com/adaptimmune-and-alpine-immune-sciences-announce-collaboration-and-license-agreement-to-develop-next-generation-spear-t-cell-products/ 2019-05-17T10:19:56+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Adaptimmune-Therapeutics-logo.png http://www.pharmajournalist.com/codexis-announces-codeevolver-technology-transfer-and-license-agreement-with-global-pharmaceutical-leader/ 2019-05-17T10:22:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/codexis-inc-logo.jpg http://www.pharmajournalist.com/aphena-pharma-solutions-approves-7m-for-expansion-by-end-of-year/ 2019-05-17T10:24:28+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/Aphena_122018-204.jpg https://pharmajournalist.com/wp-content/uploads/2019/05/Aphena_122018-204.jpg http://www.pharmajournalist.com/chiasma-and-lonza-announce-progression-of-oral-octreotide-capsules-development-and-definitive-commercial-supply-agreement/ 2019-05-17T10:26:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/lonza.jpg http://www.pharmajournalist.com/fda-approves-tracelink-dscsa-pilot-submission-for-network-solutions/ 2019-05-17T10:27:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/lsne-announces-gmp-certification-by-brazils-anvisa/ 2019-05-17T10:29:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/LSNE-Contact-Manufacturing.jpg http://www.pharmajournalist.com/probiogen-and-vaccitech-sign-license-agreement-for-probiogens-technology-platform/ 2019-05-17T10:31:33+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/ProBioGen-Logo.png http://www.pharmajournalist.com/cleanroom-industry-experts-join-the-pharmaceutical-cleanroom-technology-conference-in-october/ 2019-05-17T14:00:35+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/CleanRoom-Banner_Pharma-Journalist_SMi-Group.jpg http://www.pharmajournalist.com/registration-is-now-open-for-the-inaugural-wearable-injectors-and-connected-devices-conference-2019/ 2019-05-22T07:20:44+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/300x250.jpg http://www.pharmajournalist.com/2-weeks-until-smis-pharma-microbiology-west-coast-conference-nearly-sold-out/ 2019-05-23T08:03:06+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/Pharma-Micro-WC_Banner_Pharma-Journalist.jpg http://www.pharmajournalist.com/fda-grants-priority-review-of-invokana-canagliflozin-snda/ 2019-05-23T13:56:05+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Janssen-Pharma-Logo.jpg http://www.pharmajournalist.com/evotec-jump-starts-biologics-with-acquisition-of-just-biotherapeutics/ 2019-05-23T13:59:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/evotec.png http://www.pharmajournalist.com/merck-to-acquire-peloton-therapeutics-bolstering-oncology-pipeline/ 2019-05-23T14:01:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/catalent-completes-acquisition-of-gene-therapy-leader-paragon-bioservices-inc-for-1-2-billion/ 2019-05-23T14:02:37+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Catalent-Logo.png http://www.pharmajournalist.com/kazia-enters-clinical-collaboration-for-metastatic-brain-cancer-with-alliance-for-clinical-trials-in-oncology/ 2019-05-23T14:05:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/gotham-therapeutics-and-zobio-achieve-significant-milestone-in-epitranscriptomic-drug-discovery-collaboration/ 2019-05-23T14:09:41+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/Gotham-Therapeutics-logo.png http://www.pharmajournalist.com/halozyme-announces-argenx-has-selected-second-target-under-enhanze-technology-collaboration-and-license-agreement/ 2019-05-23T14:12:05+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/Halozyme-Logo.png http://www.pharmajournalist.com/lillys-mirikizumab-met-primary-endpoint-and-key-secondary-endpoints-in-phase-2-study-including-reductions-of-gastrointestinal-lesions/ 2019-05-23T14:15:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/wuxi-biologics-signed-letter-of-intent-for-long-term-vaccine-manufacturing-contract/ 2019-05-23T14:23:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/wuxi-biologics-logo.png http://www.pharmajournalist.com/aequus-to-supply-kensington-eye-institute-with-zepto-capsulotomy-system-extends-distribution-agreement-with-mynosys/ 2019-05-28T06:08:16+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/Aequus-Logo.png http://www.pharmajournalist.com/calecimr-forms-a-major-partnership-with-menarini-asia-pacific-to-expand-the-presence-of-its-stem-cell-skin-care-products-in-the-region/ 2019-05-28T06:09:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/avexis-receives-fda-approval-for-zolgensma-the-first-and-only-gene-therapy-for-pediatric-patients-with-spinal-muscular-atrophy-sma/ 2019-05-28T06:14:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/trovagene-announces-research-collaboration-with-nektar-therapeutics/ 2019-05-28T06:16:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/santhera-enters-into-license-agreement-with-chiesi-group-for-raxone-in-lhon-valued-at-up-to-chf-105-million/ 2019-05-28T06:20:53+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/Santhera-Pharma-Logo.jpg http://www.pharmajournalist.com/probiogen-and-abcuro-signed-glymaxx-improved-cell-line-development-and-gmp-production-agreement/ 2019-05-28T06:22:30+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/ProBioGen-Logo.png http://www.pharmajournalist.com/sgs-celebrates-the-opening-of-the-biologics-testing-facility-expansion-in-glasgow-uk/ 2019-05-28T06:24:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/sgs-logo.jpg http://www.pharmajournalist.com/thermo-fisher-scientific-to-invest-50-million-to-expand-bioproduction-capabilities/ 2019-05-28T06:26:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/thermo-fisher-scientific.jpg http://www.pharmajournalist.com/gsk-announces-approval-of-shingrix-in-china-for-prevention-of-shingles-in-adults-aged-50-and-over/ 2019-05-28T06:36:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/gsk.jpg http://www.pharmajournalist.com/new-data-show-symbicort-reduces-attacks-in-mild-asthma-when-used-as-an-anti-inflammatory-reliever/ 2019-05-28T06:47:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/pfizer-announces-top-line-results-from-phase-3-trial-of-lyrica-pregabalin-in-primary-generalized-tonic-clonic-seizures/ 2019-05-28T06:59:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/fda-approves-jakafi-ruxolitinib-for-the-treatment-of-patients-with-acute-graft-versus-host-disease/ 2019-05-28T07:15:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/duke-university-medical-centre-to-lead-a-workshop-on-the-organic-development-of-a-sustainable-academic-biobank-during-the-9th-annual-biobanking-conference/ 2019-05-29T11:16:39+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/Biobanking-Banner-SMi_Pharma-Journalist.jpg http://www.pharmajournalist.com/allergan-and-gedeon-richter-receive-fda-approval-for-expanded-use-of-vraylar-cariprazine-in-the-treatment-of-bipolar-depression/ 2019-05-31T08:42:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/allergan.jpg http://www.pharmajournalist.com/amicus-therapeutics-and-the-university-of-pennsylvania-announce-major-expansion-of-gene-therapy-collaboration/ 2019-05-31T08:44:48+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Amicus-Therapeutics-Logo.jpg http://www.pharmajournalist.com/fda-approves-revlimid-lenalidomide-in-combination-with-rituximab/ 2019-05-31T08:47:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/celgene.jpg http://www.pharmajournalist.com/lilly-announces-licensing-agreement-for-non-opioid-pain-asset-from-centrexion-therapeutics/ 2019-05-31T08:49:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/teva-announces-launch-of-a-generic-version-of-ranexa-ranolazine-extended-release-tablets-in-the-united-states/ 2019-05-31T08:52:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/TEVA-Pharma.jpg http://www.pharmajournalist.com/avexis-announces-innovative-zolgensma-gene-therapy-access-programs-for-us-payers-and-families/ 2019-05-31T08:55:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/modulus-discovery-announces-signing-of-research-data-transfer-agreement-with-astellas-pharma/ 2019-05-31T08:57:30+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/MODULUS_logo.jpg http://www.pharmajournalist.com/armas-and-micro-labs-announce-collaboration-to-launch-generic-injectables-to-u-s-market/ 2019-05-31T08:59:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/drug.jpg http://www.pharmajournalist.com/bayer-and-foundation-medicine-announce-global-collaboration-to-develop-ngs-based-companion-diagnostics-in-oncology/ 2019-05-31T09:02:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/bayer.jpg http://www.pharmajournalist.com/merz-pharma-xeomin-incobotulinumtoxina-receives-european-approval-for-treatment-of-chronic-sialorrhea-in-adults/ 2019-05-31T09:06:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merz-pharma-deutschland.jpg http://www.pharmajournalist.com/pfizer-announces-top-line-results-from-phase-3-trial-of-lyrica-pregabalin-in-primary-generalized-tonic-clonic-seizures-2/ 2019-05-31T09:09:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/ampersand-capital-partners-to-acquire-vibalogics-gmbh/ 2019-05-31T09:11:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/almac-group-appoints-dr-sheryl-foster-as-vice-president-of-quality/ 2019-05-31T09:13:18+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/Almac-Group.png https://pharmajournalist.com/wp-content/uploads/2019/05/Almac-Group.png http://www.pharmajournalist.com/vetter-works-towards-a-sustainable-energy-supply/ 2019-05-31T09:18:33+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/Vetter_works_towards_a_sustainable_energy_supply.jpg https://pharmajournalist.com/wp-content/uploads/2019/05/Vetter_works_towards_a_sustainable_energy_supply.jpg http://www.pharmajournalist.com/ema-accepts-maa-for-prestige-biopharmas-trastuzumab-biosimilar-hd201-for-review/ 2019-05-31T09:21:49+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/Prestige-Biopharma.jpg https://pharmajournalist.com/wp-content/uploads/2019/05/Prestige-Biopharma.jpg http://www.pharmajournalist.com/acerus-signs-license-agreement-to-nasal-technology-with-university-of-texas-at-austin/ 2019-05-31T09:25:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/epizyme-submits-new-drug-application-to-the-fda-for-tazemetostat-for-the-treatment-of-patients-with-epithelioid-sarcoma/ 2019-05-31T09:28:08+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/Epizyme-Logo.png http://www.pharmajournalist.com/agilvax-triggers-2-million-phase-ii-fast-track-sbir-grant-and-initiates-gmp-manufacturing/ 2019-05-31T09:42:58+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/agilvax-logo.png http://www.pharmajournalist.com/imara-announces-fda-fast-track-designation-for-imr-687-for-the-treatment-of-sickle-cell-disease/ 2019-05-31T09:46:45+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/Imara-Logo.png http://www.pharmajournalist.com/boehringer-ingelheim-and-gubra-announce-new-collaboration-to-develop-anti-obesity-peptide-poly-agonists/ 2019-05-31T09:48:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Boehringer-Ingelheim.jpg http://www.pharmajournalist.com/particle-sciences-expands-controlled-substance-capabilities-with-approval-of-dea-schedule-i/ 2019-05-31T10:19:24+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/particle-sciences-2.jpg https://pharmajournalist.com/wp-content/uploads/2019/05/particle-sciences-2.jpg http://www.pharmajournalist.com/hpapi-usa-conference-2019-insights-into-containment-and-banding-strategies/ 2019-05-31T11:35:35+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/300x250-copy.jpg http://www.pharmajournalist.com/new-program-launched-for-lyophilization-usa-2019-conference/ 2019-06-03T07:24:19+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/Lyophilization-USA-2019_Banner_Pharma-Journalist.jpg http://www.pharmajournalist.com/registration-is-live-for-the-inaugural-respiratory-drug-delivery-conference-2019/ 2019-06-03T11:19:39+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/300x250-1.jpg http://www.pharmajournalist.com/unlocking-the-potential-of-the-skin-microbiome/ 2019-06-04T08:02:25+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/Microbiome-Movement-Skin-Health_Banner_Pharma-Journalist.png http://www.pharmajournalist.com/invitation-to-join-microbiome-leaders-at-the-microbiome-movement-summit-in-singapore/ 2019-06-04T08:06:45+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/Microbiome-Movement-Asia_Banner_Pharma-Journalist.png http://www.pharmajournalist.com/astrazeneca-to-lead-a-workshop-during-the-wearable-injectors-and-connected-devices-conference-2019/ 2019-06-04T10:33:14+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/300x250.jpg http://www.pharmajournalist.com/registration-opens-for-smis-3rd-annual-ophthalmic-drugs-conference-and-focus-day/ 2019-06-05T15:40:46+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Ophthalmic-Drugs.jpg http://www.pharmajournalist.com/celgene-and-acceleron-announce-fda-accepts-luspatercept-biologics-license-application-in-myelodysplastic-syndromes-and-beta-thalassemia/ 2019-06-07T08:33:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/celgene.jpg http://www.pharmajournalist.com/bayer-and-arvinas-to-collaborate-on-human-protac-therapies-and-launch-a-separate-joint-venture-to-develop-agricultural-protac-applications/ 2019-06-07T08:36:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/bayer.jpg http://www.pharmajournalist.com/nucala-mepolizumab-receives-positive-chmp-opinion-for-new-self-administration-options/ 2019-06-07T08:40:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/fda-approves-first-treatment-for-episodic-cluster-headache-that-reduces-the-frequency-of-attacks/ 2019-06-07T08:41:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/fda-accepts-new-drug-application-for-triple-combination-tablet-for-adults-with-type-2-diabetes/ 2019-06-07T08:43:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/fda-approves-mercks-zerbaxa-ceftolozane-and-tazobactam-3g-dose-for-the-treatment-of-adults-with-habp-vabp/ 2019-06-07T08:47:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/advanced-accelerator-applications-receives-positive-chmp-opinion-for-lysakare/ 2019-06-07T08:51:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/vertex-expands-into-new-disease-areas-and-enhances-gene-editing-capabilities-through-expanded-collaboration-with-crispr-therapeutics-and-acquisition-of-exonics-therapeutics/ 2019-06-07T08:55:37+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Vertex.jpg http://www.pharmajournalist.com/innovation-pharma-signs-agreement-for-advanced-oral-tablet-technology-in-treating-inflammatory-bowel-disease/ 2019-06-07T08:58:05+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Innovation-Pharma-Logo.png http://www.pharmajournalist.com/abveris-and-tetragenetics-announce-antibody-discovery-collaboration/ 2019-06-07T09:00:48+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/abveris-logo.png http://www.pharmajournalist.com/peptidream-announces-strategic-partnership-with-drug-delivery-expert-pharmain/ 2019-06-07T09:03:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/peptiDream-logo.jpg http://www.pharmajournalist.com/enable-injections-enters-into-strategic-partnership-with-sanofi/ 2019-06-07T09:07:37+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Enable-Injections.jpg https://pharmajournalist.com/wp-content/uploads/2019/06/Enable-Injections.jpg http://www.pharmajournalist.com/thermo-fisher-scientific-announces-collaboration-with-newomics-to-advance-disease-biomarker-validation/ 2019-06-07T09:09:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/thermo-fisher-scientific.jpg http://www.pharmajournalist.com/biocartis-and-kite-sign-agreement-for-development-of-assays-supporting-kites-therapies/ 2019-06-07T09:13:17+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Biocartis-Logo.jpg http://www.pharmajournalist.com/novartis-presents-first-of-its-kind-histology-data-with-iscalimab/ 2019-06-07T09:23:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/cstone-received-approval-to-initiate-clinical-development-in-china-of-cs1001-and-blu-554-cs3008-in-combination-therapy-for-hcc/ 2019-06-07T09:31:36+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/cstone-logo.jpg http://www.pharmajournalist.com/reata-receives-orphan-drug-designation-for-bardoxolone-methyl-for-the-treatment-of-autosomal-dominant-polycystic-kidney-disease/ 2019-06-07T09:34:52+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Reata-Pharmaceuticals-Logo.jpg http://www.pharmajournalist.com/imfinzi-demonstrates-overall-survival-at-three-years-in-unresectable-stage-iii-nsclc/ 2019-06-07T09:37:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/goldfinch-bio-initiates-phase-1-clinical-trial-of-gfb-887-for-kidney-disease/ 2019-06-07T09:41:41+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Goldfinch-Bio-Logo.png http://www.pharmajournalist.com/evotec-and-celgene-further-expand-ipsc-collaboration-including-new-cell-type/ 2019-06-07T09:45:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/evotec.png http://www.pharmajournalist.com/servier-appoints-yposkesi-for-lentiviral-vector-gmp-manufacturing-in-car-t-cell-development-technology/ 2019-06-07T09:53:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Servier-CDMO.png http://www.pharmajournalist.com/cambrex-completes-new-process-and-analytical-development-facility-at-its-karlskoga-sweden-manufacturing-site/ 2019-06-07T09:55:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/cambrex.jpeg http://www.pharmajournalist.com/sterling-announces-pilot-plant-facility-expansion-is-operational/ 2019-06-07T09:57:26+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sterling-pharma-solutions.jpg http://www.pharmajournalist.com/aldevron-to-build-14-acre-gene-therapy-manufacturing-campus/ 2019-06-07T10:01:31+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/campus-aerial-nw-home.jpg http://www.pharmajournalist.com/wp-content/uploads/2019/06/campus-aerial-nw-home.jpg http://www.pharmajournalist.com/rick-thompson-ceo-at-findacure-invitation-to-smis-orphan-drugs-rare-diseases-conference-2019/ 2019-06-11T07:23:35+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/300x250-P-300-.jpg http://www.pharmajournalist.com/smi-invites-cleanroom-experts-to-join-pharma-cleanroom-technology-conference/ 2019-06-13T10:02:41+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/CleanRoom-Banner_Pharma-Journalist_SMi-Group.jpg http://www.pharmajournalist.com/genmab-signs-agreement-with-janssen-for-next-generation-cd38-antibody-hexabody-cd38/ 2019-06-14T08:17:02+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/fda-approves-two-new-indications-for-mercks-keytruda-pembrolizumab/ 2019-06-14T08:19:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/merck-to-acquire-tilos-therapeutics/ 2019-06-14T08:23:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/sobi-acquires-emapalumab-and-related-assets/ 2019-06-14T08:26:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/sobi.jpg http://www.pharmajournalist.com/deciphera-and-zai-lab-limited-announce-an-exclusive-license-agreement-for-ripretinib-in-greater-china/ 2019-06-14T08:30:11+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Deciphera-Logo.png http://www.pharmajournalist.com/gt-apeiron-therapeutics-launched-by-gt-healthcare-capital-partners-signs-with-exscientia/ 2019-06-14T08:34:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/fda-grants-roches-polivy-accelerated-approval-for-people-with-previously-treated-aggressive-lymphoma/ 2019-06-14T08:42:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/biogen-completes-acquisition-of-nightstar-therapeutics-for-approximately-800-million/ 2019-06-14T08:44:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Biogen-logo.jpg http://www.pharmajournalist.com/telix-pharmaceuticals-and-eczacibasi-monrol-sign-manufacturing-and-distribution-agreement/ 2019-06-14T08:48:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/eton-pharma-announces-licensing-of-lamotrigine-new-drug-application-and-provides-pipeline-update/ 2019-06-14T08:54:12+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Eton-Pharma-Logo.png http://www.pharmajournalist.com/boehringer-and-university-of-dundee-highlight-successful-protac-drug-discovery-program-and-extend-their-ongoing-anti-cancer-alliance/ 2019-06-14T08:55:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/harbour-biomed-and-erasmus-mc-sign-mou-to-advance-next-generation-immuno-oncology-and-immunology-drug-discovery-and-clinical-development/ 2019-06-14T08:57:57+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Harbour-BioMed-Logo.jpg http://www.pharmajournalist.com/biomx-licenses-novel-targets-for-liver-disease-phage-therapy-program-from-jsr-corporation-in-japan/ 2019-06-14T08:59:37+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/biomxlogo.png http://www.pharmajournalist.com/aptar-acquires-nanopharm-and-gateway-analytical/ 2019-06-14T09:01:04+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Aptar-Pharma-Logo.jpg http://www.pharmajournalist.com/hoth-therapeutics-to-begin-production-of-biolexa-therapeutic-for-upcoming-toxicology-and-clinical-trials/ 2019-06-14T09:03:36+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Hoth-Therapeutics-Logo.jpg http://www.pharmajournalist.com/cstone-and-bayer-announce-global-collaboration-to-evaluate-pd-l1-monoclonal-antibody-cs1001-in-combination-with-regorafenib/ 2019-06-14T09:04:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/bayer.jpg http://www.pharmajournalist.com/fda-approves-amgen-and-allergans-kanjinti-trastuzumab-anns-a-biosimilar-to-herceptin-trastuzumab/ 2019-06-14T09:13:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/novartis-cosentyx-first-to-show-efficacy-in-all-key-manifestations-of-psoriatic-arthritis/ 2019-06-14T09:15:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/debiopharm-and-ipsen-extend-their-strategic-decapeptyl-triptorelin-partnership-for-another-15-years/ 2019-06-14T09:16:41+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Ipsen-Group-Image.jpg http://www.pharmajournalist.com/fda-grants-genentechs-polivy-accelerated-approval-for-people-with-previously-treated-aggressive-lymphoma/ 2019-06-14T09:20:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/pfizer-announces-results-from-xeljanz-xr-tofacitinib-oral-shift-study/ 2019-06-14T09:23:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/camargo-enhances-drug-development-services-through-acquisition-of-montreal-based-insymbiosis/ 2019-06-14T09:29:06+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Camargo-Logo.png http://www.pharmajournalist.com/saga-raises-40-million-sek-e3-7-million-to-advance-ultrasensitive-cancer-liquid-biopsies/ 2019-06-14T09:32:37+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/SAGA_logo.png http://www.pharmajournalist.com/terns-pharmaceuticals-initiates-a-phase-1-clinical-trial-of-tern-101/ 2019-06-14T09:35:42+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Terns-Pharma-Logo.png http://www.pharmajournalist.com/exclusive-interview-with-dr-zisis-kozlakidis-released-ahead-of-smis-upcoming-biobanking-2019-conference/ 2019-06-18T07:51:51+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/Biobanking-Banner-SMi_Pharma-Journalist.jpg http://www.pharmajournalist.com/the-department-for-international-trade-to-present-at-smis-wearable-injectors-and-connected-devices-conference/ 2019-06-19T10:19:54+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/300x250.jpg http://www.pharmajournalist.com/pfizer-to-lead-a-post-conference-workshop-at-lyophilization-usa-2019/ 2019-06-20T07:29:52+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/300x250-1.jpg http://www.pharmajournalist.com/pfizer-to-acquire-array-biopharma/ 2019-06-21T08:22:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/gilead-and-nurix-establish-strategic-collaboration-to-develop-novel-therapies-for-cancer-and-other-diseases/ 2019-06-21T08:24:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/amgen-and-the-institute-for-protein-design-ipd-at-university-of-washington-announce-unique-strategic-research-partnership/ 2019-06-21T08:26:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg http://www.pharmajournalist.com/ricoh-announces-strategic-business-partnership-with-elixirgen-scientific/ 2019-06-21T08:28:54+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Ricoh-Imgaes.gif http://www.pharmajournalist.com/lynparza-approved-in-japan-for-1st-line-maintenance-therapy-in-brca-mutated-advanced-ovarian-cancer/ 2019-06-21T08:38:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/japan-becomes-the-first-country-to-approve-roches-personalised-medicine-rozlytrek/ 2019-06-21T08:39:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/fda-approves-new-treatment-for-pediatric-patients-with-type-2-diabetes/ 2019-06-21T08:41:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/sanofi-and-regeneron-announce-positive-topline-phase-2-results-for-il-33-antibody-in-asthma/ 2019-06-21T08:42:59+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/sanofi-and-google-to-develop-new-healthcare-innovation-lab/ 2019-06-21T08:44:19+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/theravance-biopharma-and-mylan-expand-yupelri-revefenacin-development-and-commercialization-agreement-to-include-china-and-adjacent-territories/ 2019-06-21T08:46:20+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Theravance-biopharma-logo.png http://www.pharmajournalist.com/wuxi-biologics-to-expand-integrated-biologics-conjugation-solution-center-to-include-commercial-manufacturing/ 2019-06-21T08:48:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/wuxi-biologics-logo.png http://www.pharmajournalist.com/ultragenyx-and-arcturus-expand-existing-research-collaboration-and-license-agreement-to-develop-additional-nucleic-acid-therapies-for-rare-diseases/ 2019-06-21T08:50:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Ultragenyxlogo.gif http://www.pharmajournalist.com/premier-inc-partners-with-pensiamo-inc-and-upmc-to-launch-ai-powered-pharmaceutical-supply-chain-solution/ 2019-06-21T08:53:41+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Premier-Inc-Logo.jpg http://www.pharmajournalist.com/thermogenesis-receives-health-canada-approval-of-its-next-generation-axp-ii-system-for-cord-blood-processing/ 2019-06-21T08:58:15+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/thermogenesis-logo.png http://www.pharmajournalist.com/casi-pharmaceuticals-acquires-worldwide-rights-to-commercialize-anti-cd19-t-cell-therapy/ 2019-06-21T08:59:43+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/casi-pharmaceuticals-logo.png http://www.pharmajournalist.com/halo-labs-to-expand-globally-and-acquire-bophelo-bioscience/ 2019-06-21T09:02:59+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Halo-Labs-Logo.jpg http://www.pharmajournalist.com/ironwood-and-allergan-report-positive-topline-data-from-phase-iiib-trial-of-linzess-linaclotide-in-adults-with-ibs-c/ 2019-06-21T09:06:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/allergan.jpg http://www.pharmajournalist.com/boehringer-ose-doses-first-patient-in-phase-1-trial-of-sirp%ce%b1-antagonist-monoclonal-antibody/ 2019-06-21T09:08:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/cymabay-reports-topline-12-week-data-from-an-ongoing-phase-2b-study-of-seladelpar-in-patients-with-nash/ 2019-06-21T09:16:01+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/CymaBay-Logo.jpg http://www.pharmajournalist.com/axovant-and-yposkesi-sign-strategic-gene-therapy-development-and-manufacturing-partnership/ 2019-06-21T09:17:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/gamida-cell-and-lonza-establish-commercial-manufacturing-agreement-for-omidubicel/ 2019-06-21T09:25:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/lonza.jpg http://www.pharmajournalist.com/catalent-to-purchase-bristol-myers-squibb-manufacturing-facility-in-anagni-italy/ 2019-06-21T09:27:31+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Catalent-Logo.png http://www.pharmajournalist.com/cognizant-to-acquire-zenith-technologies/ 2019-06-21T09:31:14+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Cognizant-Logo.png http://www.pharmajournalist.com/cytovance-biologics-completes-its-second-fda-pre-approval-inspection-pai-of-oklahoma-city-ok-facilities/ 2019-06-21T09:34:12+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Cytovance-Biologics-logo.jpg http://www.pharmajournalist.com/lsne-completes-acquisition-of-sterile-injectables-manufacturing-facility-located-in-leon-spain/ 2019-06-21T09:44:56+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/LSNEs-New-Lab-Space.jpg http://www.pharmajournalist.com/voyager-therapeutics-announces-restructured-gene-therapy-relationship-with-sanofi-genzyme-and-portfolio-update/ 2019-06-21T09:47:23+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Voyager-Therapeutics-Logo.png http://www.pharmajournalist.com/the-need-for-a-blueprint-emergency-plan-to-avoid-a-hpapi-crisis/ 2019-06-24T13:10:03+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/300x250-copy.jpg http://www.pharmajournalist.com/new-brochure-released-for-the-pharmaceutical-cleanroom-technology-europe-conference-2019/ 2019-06-26T07:37:47+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/CleanRoom-Banner_Pharma-Journalist_SMi-Group.jpg http://www.pharmajournalist.com/exclusive-interview-with-stephen-murby-of-asbm-released-ahead-of-upcoming-biosimilars-conference/ 2019-06-27T07:28:17+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/P-298-Biosimilars-300x250.jpg http://www.pharmajournalist.com/plans-for-rocklatan-to-launch-in-europe/ 2019-06-27T07:47:40+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Ophthalmic-Drugs.jpg http://www.pharmajournalist.com/alexion-pharmaceuticals-and-minoryx-therapeutics-to-present-at-smis-orphan-drugs-rare-diseases-event/ 2019-06-27T11:20:22+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/300x250-P-300-.jpg http://www.pharmajournalist.com/eib-finances-almiralls-research-into-new-skin-disease-treatments/ 2019-06-28T07:46:15+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/Almirall.jpg http://www.pharmajournalist.com/fda-approves-dupixent-dupilumab-for-chronic-rhinosinusitis-with-nasal-polyposis/ 2019-06-28T07:48:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/regeneron.jpg http://www.pharmajournalist.com/genfit-and-terns-announce-228mm-strategic-partnership-to-develop-and-commercialize-elafibranor-in-greater-china/ 2019-06-28T07:54:06+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Partnership.jpg http://www.pharmajournalist.com/abbvie-to-acquire-allergan-in-transformative-move-for-both-companies/ 2019-06-28T08:18:36+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/molnlycke-and-zuellig-pharma-strengthen-partnership-for-advanced-wound-care-solutions-in-south-east-asia/ 2019-06-28T08:25:58+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Granulox-and-Granudacyn.png http://www.pharmajournalist.com/wp-content/uploads/2019/06/Granulox-and-Granudacyn.png http://www.pharmajournalist.com/aucta-pharmaceuticals-announces-licensing-of-lamotrigine-new-drug-application/ 2019-06-28T08:29:12+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Aucta-Pharmaceuticals-Logo.jpg http://www.pharmajournalist.com/rafael-pharmaceuticals-enters-into-out-licensing-agreement-with-ono-pharmaceutical/ 2019-06-28T08:31:28+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/Rafael-pharma-logo.png http://www.pharmajournalist.com/liquidia-and-gsk-restructure-collaboration-agreement/ 2019-06-28T08:32:49+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Liquidia-Technologies.jpg http://www.pharmajournalist.com/tlc-announces-development-and-license-agreement-with-birdie-biopharmaceuticals-for-nanox-immunotherapy-product/ 2019-06-28T08:34:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/intensity-therapeutics-announces-clinical-collaboration-with-merck/ 2019-06-28T08:35:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/gilead-and-carna-biosciences-announce-research-and-development-collaboration-to-develop-novel-immuno-oncology-therapies/ 2019-06-28T08:38:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/c4x-discovery-and-phoremost-collaboration-to-accelerate-parkinsons-disease-drug-discovery-pipeline/ 2019-06-28T08:41:55+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Partnership.jpg http://www.pharmajournalist.com/arrowhead-pharmaceuticals-receives-orphan-drug-designation-for-aro-apoc3/ 2019-06-28T08:43:25+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/arrowhead-pharma-logo.jpg http://www.pharmajournalist.com/imbrium-initiates-phase-2-study-of-imb-115-in-insomnia-associated-with-alcohol-cessation/ 2019-06-28T08:47:40+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Imbrium-Therapeutics-Logo.png http://www.pharmajournalist.com/akorn-receives-fda-warning-letter/ 2019-06-28T08:52:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/contravir-pharmaceuticals-submits-ind-application-for-crv431-for-nash/ 2019-06-28T09:00:18+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/ContraVir-Logo.png http://www.pharmajournalist.com/sungen-announces-to-partner-with-athenex-to-launch-bivalirudin-through-piv-challenges-in-us/ 2019-06-28T09:02:22+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/SunGen-Pharma-Logo.png http://www.pharmajournalist.com/oxford-biotherapeutics-announces-receipt-of-a-milestone-payment-as-boehringer-advances-an-oncology-drug-candidate/ 2019-06-28T09:04:30+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/Oxford-Biotherapeutics-Logo.jpg http://www.pharmajournalist.com/velabs-therapeutics-announces-e3-million-series-b-financing-to-advance-its-functional-antibody-screening-programme/ 2019-06-28T09:06:53+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Velabs.jpg http://www.pharmajournalist.com/new-ambr-250-modular-bioreactor-vessel-launched-for-cell-and-gene-therapy-applications/ 2019-06-28T09:10:44+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/New-ambr-250.jpg http://www.pharmajournalist.com/wp-content/uploads/2019/06/New-ambr-250.jpg http://www.pharmajournalist.com/prestige-biopharma-reports-positive-top-line-phase-iii-results-for-tuznue-trastuzumab-biosimilar/ 2019-06-28T09:23:11+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Prestige-Bi.jpg http://www.pharmajournalist.com/clinigen-broadens-partnership-with-accord-healthcare-to-supply-and-distribute-cardioxane-and-savene-in-poland/ 2019-06-28T09:25:05+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/Clinigen-Logo.png http://www.pharmajournalist.com/peptidream-announces-new-peptide-drug-conjugate-collaboration-agreement-with-novartis/ 2019-06-28T09:27:24+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/PeptiDream-Logo.jpg http://www.pharmajournalist.com/advancing-the-use-generation-of-real-world-evidence-across-drug-life-cycle/ 2019-07-01T12:11:07+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/RWE-Pharma-Journalist-Banners.png http://www.pharmajournalist.com/wp-content/uploads/2019/06/RWE-Pharma-Journalist-Banners.png http://www.pharmajournalist.com/ensuring-safer-drugs-to-market-by-analyzing-latest-developments-in-pharmacovigilance-drug-safety-and-risk-management/ 2019-07-03T09:27:08+00:00 https://pharmajournalist.com/wp-content/uploads/2019/07/19th-PV-300x250-px-size-banner-BRONZE-SPONSOR-4C-PHARMA.jpg http://www.pharmajournalist.com/optima-to-host-post-conference-workshop-at-lyophilization-usa/ 2019-07-05T11:23:32+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/Lyophilization-USA-2019_Banner_Pharma-Journalist.jpg http://www.pharmajournalist.com/fda-approves-new-treatment-for-refractory-multiple-myeloma/ 2019-07-05T12:15:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/viiv-healthcare-receives-eu-marketing-authorisation-for-dovato/ 2019-07-05T12:21:19+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/VIIV-Healthcare-Logo.jpg http://www.pharmajournalist.com/pfizer-completes-acquisition-of-therachon/ 2019-07-05T12:23:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/cancer-research-uk-forms-partnership-with-sv-health-investors-in-life-sciences-investment-fund-to-accelerate-development-of-cancer-medicines/ 2019-07-05T12:27:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/cancer-research-uk.png http://www.pharmajournalist.com/boehringer-expands-nash-rd-pipeline-with-new-first-in-class-compound-from-yuhan-corporation/ 2019-07-05T12:30:28+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/china-sxt-pharmaceuticals-announces-tcm-homologous-supplements-production/ 2019-07-05T12:46:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/drug-discovery.jpg http://www.pharmajournalist.com/telix-pharmaceuticals-and-grupo-rph-sign-latam-manufacturing-and-distribution-agreement/ 2019-07-05T12:48:05+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Telix-Pharmaceuticals-Logo.jpg http://www.pharmajournalist.com/asieris-and-photocure-enter-into-a-license-agreement-for-world-wide-development-and-commercialization-of-cevira/ 2019-07-05T12:49:55+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/ptc-therapeutics-announces-strategic-gene-therapy-licensing-agreement-with-odylia-therapeutics/ 2019-07-05T12:54:51+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/PTC-therapeutics-logo.jpg http://www.pharmajournalist.com/gsk-announces-phase-iii-start-for-its-anti-gm-csf-antibody-otilimab-in-patients-with-rheumatoid-arthritis-ra/ 2019-07-05T12:58:02+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/sandoz-launches-oncology-generic-gefitinib-in-13-eu-countries-at-loss-of-market-exclusivity-expanding-access-to-essential-medicine/ 2019-07-05T13:01:41+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/dicerna-to-begin-clinical-development-of-dcr-a1at-for-treatment-of-patients-with-alpha-1-antitrypsin-deficiency-associated-liver-disease/ 2019-07-05T13:05:00+00:00 https://pharmajournalist.com/wp-content/uploads/2019/07/Dicerna-Logo.png http://www.pharmajournalist.com/roche-announces-positive-results-for-first-global-phase-iii-study-investigating-one-dose-xofluza-baloxavir-marboxil-in-children-with-flu/ 2019-07-05T13:12:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/grifols-announces-fda-approval-of-xembify-20-subcutaneous-immunoglobulin-for-primary-immunodeficiencies/ 2019-07-05T13:15:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/grifols.png http://www.pharmajournalist.com/amicus-therapeutics-and-catalent-biologics-enter-strategic-partnership-for-gene-therapy-development-and-manufacturing/ 2019-07-05T13:19:45+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Amicus-Therapeutics-Logo.jpg http://www.pharmajournalist.com/lonza-to-acquire-sterile-fill-and-finish-facility-from-novartis/ 2019-07-05T13:21:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/lonza.jpg http://www.pharmajournalist.com/confo-therapeutics-and-dynabind-announce-drug-discovery-collaboration-to-identify-novel-gpcr-modulating-compounds/ 2019-07-05T13:24:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/Confo-Therapeutics-logo.png http://www.pharmajournalist.com/incyte-and-zai-lab-announce-collaboration-and-license-agreement-for-incmga0012-in-greater-china/ 2019-07-05T13:32:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/incyte-logo.jpg http://www.pharmajournalist.com/appili-signs-3m-usd-grant-contract-with-the-united-states-department-of-defense-to-develop-antibiotics-that-target-superbugs/ 2019-07-05T13:36:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/leo-pharma-completes-the-acquisition-of-bayers-prescription-dermatology-business/ 2019-07-05T13:39:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/leo-pharma.jpg http://www.pharmajournalist.com/semma-therapeutics-announces-pre-clinical-proof-of-concept-in-two-lead-programs-in-type-1-diabetes/ 2019-07-05T13:47:26+00:00 https://pharmajournalist.com/wp-content/uploads/2019/07/Semma-Therapeutics-Logo.jpg http://www.pharmajournalist.com/the-latest-innovations-in-hpapi-manufacturing-technologies/ 2019-07-09T08:23:46+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/300x250-copy.jpg http://www.pharmajournalist.com/conference-brochure-for-the-inaugural-respiratory-drug-delivery-now-available/ 2019-07-09T10:59:45+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/300x250.jpg http://www.pharmajournalist.com/under-the-spotlight-amgens-vp-for-the-center-of-observational-research-will-discuss-the-role-of-rwe-in-a-comprehensive-product-evidence-generation-plan/ 2019-07-09T14:08:38+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/RWE-Pharma-Journalist-Banners.png http://www.pharmajournalist.com/inauguration-of-b3dd-the-blood-brain-barrier-drug-delivery-summit-in-august-2019/ 2019-07-11T11:33:23+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/B3DD-Banners.jpg http://www.pharmajournalist.com/sanofi-fda-to-review-isatuximab-as-a-potential-treatment-for-relapsed-refractory-multiple-myeloma/ 2019-07-12T08:49:53+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/priority-review-granted-to-beigenes-supplemental-new-drug-application-in-china-for-tislelizumab-in-urothelial-carcinoma/ 2019-07-12T08:56:25+00:00 https://pharmajournalist.com/wp-content/uploads/2019/07/BeiGene-Logo.png http://www.pharmajournalist.com/ligand-announces-positive-top-line-results-from-phase-1-clinical-trial-of-captisol-enabled-iohexol/ 2019-07-12T09:03:12+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Ligand-Pharmaceuticals-logo.png http://www.pharmajournalist.com/ligand-and-sq-innovation-enter-into-exclusive-worldwide-captisol-license-and-supply-agreements-for-high-concentration-furosemide-formulation/ 2019-07-12T09:04:36+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Ligand-Pharmaceuticals-logo.png http://www.pharmajournalist.com/mirati-announces-clinical-collaboration-to-evaluate-mrtx849-in-combination-with-shp2-inhibitor-tno155/ 2019-07-12T09:06:57+00:00 https://pharmajournalist.com/wp-content/uploads/2019/07/Mirati-Therapeutics-Logo.png http://www.pharmajournalist.com/imaginab-announces-collaboration-on-cd8-imaging-agent-with-roche/ 2019-07-12T09:08:22+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Partnership.jpg http://www.pharmajournalist.com/lyndra-therapeutics-and-gilead-sciences-to-collaborate-on-development-of-ultra-long-acting-hiv-therapeutics/ 2019-07-12T09:11:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/altimmune-signs-definitive-agreement-to-acquire-spitfire-pharma-inc-adding-nash-drug-candidate-to-portfolio/ 2019-07-12T09:16:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/macrogenics-and-i-mab-announce-exclusive-collaboration-and-license-agreement-to-develop-and-commercialize-enoblituzumab-in-greater-china/ 2019-07-12T09:19:47+00:00 https://pharmajournalist.com/wp-content/uploads/2019/07/MacroGenics-Logo.jpg http://www.pharmajournalist.com/jazz-pharmaceuticals-acquires-pre-clinical-pan-raf-inhibitor-program-from-redx-pharma/ 2019-07-12T09:22:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/jazz-pharmaceuticals.jpg http://www.pharmajournalist.com/nexus-pharmaceuticals-to-build-industry-leading-sterile-injectable-manufacturing-facility-in-pleasant-prairie-wisconsin/ 2019-07-12T09:25:58+00:00 https://pharmajournalist.com/wp-content/uploads/2019/07/Nexus_Angle_Close.jpg https://pharmajournalist.com/wp-content/uploads/2019/07/Nexus_Angle_Close.jpg http://www.pharmajournalist.com/celsius-therapeutics-signs-collaboration-agreement-with-janssen-to-identify-response-biomarkers-for-ulcerative-colitis/ 2019-07-12T09:27:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/neurorx-initiates-pivotal-study-for-nrx-101-a-breakthrough-designation-therapy-targeting-suicidal-bipolar-depression/ 2019-07-12T09:34:19+00:00 https://pharmajournalist.com/wp-content/uploads/2019/07/NeuroRx-Logo.jpg http://www.pharmajournalist.com/schreiner-medipharm-introduces-multi-tear-closure-label-for-double-tamper-protection-in-pharmaceutical-packaging/ 2019-07-12T09:36:23+00:00 https://pharmajournalist.com/wp-content/uploads/2019/07/csm_SMP_Multi-Tear_Closure_Label.jpg http://www.pharmajournalist.com/wp-content/uploads/2019/07/csm_SMP_Multi-Tear_Closure_Label.jpg http://www.pharmajournalist.com/passage-bio-announces-new-dedicated-gene-therapy-manufacturing-suite/ 2019-07-12T09:39:20+00:00 https://pharmajournalist.com/wp-content/uploads/2019/07/Passage-Bio-Logo.jpg http://www.pharmajournalist.com/extensive-expansion-at-lonzas-tampa-site-provides-streamlined-services-for-solid-oral-dosage-forms/ 2019-07-12T09:41:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/lonza.jpg http://www.pharmajournalist.com/cytomx-therapeutics-announces-second-target-selection-and-program-initiation-with-abbvie-under-ongoing/ 2019-07-12T09:57:33+00:00 https://pharmajournalist.com/wp-content/uploads/2019/07/Cytomx-Logo.jpg http://www.pharmajournalist.com/reachbio-research-labs-offers-new-services-for-adc-off-target-toxicity-and-linker-stability/ 2019-07-12T09:59:54+00:00 https://pharmajournalist.com/wp-content/uploads/2019/07/REACHBIO-LOGO.png http://www.pharmajournalist.com/sungen-pharma-receives-sixth-anda-approval-from-us-fda/ 2019-07-12T10:08:41+00:00 https://pharmajournalist.com/wp-content/uploads/2019/07/SunGen-Pharma-Logo.jpg http://www.pharmajournalist.com/catalent-extends-global-commercial-spray-drying-capabilities-in-europe/ 2019-07-12T10:10:20+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Catalent-Logo.png http://www.pharmajournalist.com/sotio-initiates-first-in-human-clinical-trial-with-il-15-superagonist-so-c101/ 2019-07-12T10:13:00+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Sotio-Logo.jpg http://www.pharmajournalist.com/teva-completes-facilities-purchase-in-pennsylvania-for-north-america-research-development-campus/ 2019-07-12T10:16:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/TEVA-Pharma.jpg http://www.pharmajournalist.com/13-reasons-to-be-a-part-of-smis-cleanroom-technology-conference/ 2019-07-12T11:22:23+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/CleanRoom-Banner_Pharma-Journalist_SMi-Group.jpg http://www.pharmajournalist.com/exclusive-speaker-interview-with-iveena-released-for-3rd-ophthalmic-drugs-conference/ 2019-07-16T09:01:24+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Ophthalmic-Drugs.jpg http://www.pharmajournalist.com/exclusive-interview-with-astrazeneca-ahead-of-upcoming-wearable-injectors-connected-devices/ 2019-07-17T08:05:12+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/300x250.jpg http://www.pharmajournalist.com/10-key-reasons-to-attend-smis-10th-annual-biosimilars-conference/ 2019-07-18T11:10:08+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/P-298-Biosimilars-300x250.jpg http://www.pharmajournalist.com/astellas-and-frequency-therapeutics-enter-into-license-agreement-for-fx-322-a-regenerative-treatment-candidate-for-hearing-loss/ 2019-07-19T09:17:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astellas.jpg http://www.pharmajournalist.com/inflection-biosciences-and-aum-biosciences-announce-global-license-agreement-for-pim-pi3k-mtor-inhibitors/ 2019-07-19T09:19:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/sosei-heptares-enters-into-multi-target-research-collaboration-and-license-agreement-with-genentech/ 2019-07-19T09:21:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/kite-announces-plans-to-bolster-industry-leading-cell-therapy-manufacturing-capabilities-with-new-viral-vector-facility/ 2019-07-19T09:24:04+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Kite-Gilead-Company.png http://www.pharmajournalist.com/am-pharma-raises-e116m-133m-to-conduct-pivotal-phase-iii-trial-of-recap-in-acute-kidney-injury/ 2019-07-19T09:26:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.png http://www.pharmajournalist.com/boehringer-ingelheim-acquires-amal-therapeutics/ 2019-07-19T09:28:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/inmark-results-suggest-prompt-treatment-of-ipf-with-antifibrotics-to-slow-disease-progression/ 2019-07-19T09:30:28+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Boehringer-Ingelheim.jpg http://www.pharmajournalist.com/abbvie-enhances-early-stage-oncology-pipeline-with-acquisition-of-mavupharma/ 2019-07-19T09:32:11+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/fda-accepts-file-and-accelerates-review-of-novartis-sickle-cell-disease-medicine-crizanlizumab-seg101/ 2019-07-19T09:36:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/novartis-key-multiple-sclerosis-product-gilenya-approved-in-china/ 2019-07-19T09:37:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/dicerna-receives-breakthrough-therapy-designation-for-dcr-phxc-for-treatment-of-primary-hyperoxaluria-type-1-ph1/ 2019-07-19T09:42:35+00:00 https://pharmajournalist.com/wp-content/uploads/2019/07/Dicerna-Logo.png http://www.pharmajournalist.com/mallinckrodt-and-silence-therapeutics-announce-collaboration-to-develop-and-commercialize-rnai-therapeutics-for-complement-mediated-diseases/ 2019-07-19T09:46:28+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/mallinckrodt-pharma.jpg http://www.pharmajournalist.com/epistem-licence-hubrecht-organoid-technology-to-expand-pre-clinical-toxicology-service-portfolio/ 2019-07-19T09:49:22+00:00 https://pharmajournalist.com/wp-content/uploads/2019/07/epistem-logo-RS.png http://www.pharmajournalist.com/milliporesigma-and-broad-institute-announce-crispr-license-framework-to-encourage-innovation/ 2019-07-19T10:04:14+00:00 https://pharmajournalist.com/wp-content/uploads/2019/07/MilliporeSigma.jpg http://www.pharmajournalist.com/wp-content/uploads/2019/07/MilliporeSigma.jpg http://www.pharmajournalist.com/tracelink-partners-with-excellis-to-provide-local-implementation-services-for-its-russia-compliance-solution-through-one-global-compliance-platform/ 2019-07-19T10:05:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/tracelink-logo.png http://www.pharmajournalist.com/quotient-sciences-to-recapitalize-with-global-private-equity-firm-permira/ 2019-07-19T10:07:43+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Quotient-Sciences-Logo.jpg http://www.pharmajournalist.com/lonza-selects-rockwell-automation-for-digital-transformation-of-pharmaceutical-operations/ 2019-07-19T10:09:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/Lonza.jpg http://www.pharmajournalist.com/janssen-seeks-ema-approval-for-novel-subcutaneous-formulation-of-darzalex-daratumumab/ 2019-07-19T10:13:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/Janssen.jpg http://www.pharmajournalist.com/aridis-receives-orphan-drug-designation-from-the-european-medicines-agency-for-ar-501/ 2019-07-19T10:18:14+00:00 https://pharmajournalist.com/wp-content/uploads/2019/07/Aridis-Pharma-Logo.png http://www.pharmajournalist.com/amgen-and-allergans-mvasi-bevacizumab-awwb-and-kanjinti-trastuzumab-anns-now-available-in-the-united-states/ 2019-07-19T10:22:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg http://www.pharmajournalist.com/celltrion-and-nan-fung-group-to-establish-vcell-healthcare-limited-to-develop-and-commercialize-biosimilars-in-china/ 2019-07-19T10:24:08+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/celltrion-Image.png http://www.pharmajournalist.com/fda-approves-new-treatment-for-complicated-urinary-tract-and-complicated-intra-abdominal-infections/ 2019-07-19T10:27:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/three-interactive-sessions-to-take-place-at-the-respiratory-drug-delivery-conference/ 2019-07-19T13:08:44+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/300x250.jpg http://www.pharmajournalist.com/gemphire-therapeutics-and-neurobo-announce-merger-agreement-to-advance-a-neurodegenerative-disease-company/ 2019-07-26T08:58:43+00:00 https://pharmajournalist.com/wp-content/uploads/2019/07/Gemphire-Logo.jpeg http://www.pharmajournalist.com/cepi-awards-up-to-us23-4-million-to-valneva-for-late-stage-development-of-a-single-dose-chikungunya-vaccine/ 2019-07-26T09:02:21+00:00 https://pharmajournalist.com/wp-content/uploads/2019/07/Valneva-Logo.png http://www.pharmajournalist.com/fda-approves-otezla-apremilast-for-the-treatment-of-oral-ulcers-associated-with-behcets-disease/ 2019-07-26T09:08:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/johnson-johnson-establishes-international-consortium-to-advance-pioneering-science-in-the-fight-to-end-tuberculosis/ 2019-07-26T09:10:16+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Johnson-Johnson-Logo.png http://www.pharmajournalist.com/merck-and-eisai-receive-third-breakthrough-therapy-designation-from-fda-for-keytruda-pembrolizumab-plus-lenvima-lenvatinib-combination-treatment/ 2019-07-26T09:15:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/vertex-submits-new-drug-application-to-the-fda-for-triple-combination-regimen-of-vx-445-elexacaftor-tezacaftor-and-ivacaftor-in-cystic-fibrosis/ 2019-07-26T09:16:56+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Vertex.jpg http://www.pharmajournalist.com/fda-approves-pfizers-biosimilar-ruxience-rituximab-pvvr-for-certain-cancers-and-autoimmune-conditions/ 2019-07-26T09:18:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/sanofi-signs-strategic-deal-for-exclusive-us-over-the-counter-rights-to-tamiflu-in-flu-care/ 2019-07-26T09:20:43+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/epizyme-announces-fda-filing-acceptance-of-new-drug-application-and-priority-review-for-tazemetostat-for-the-treatment-of-epithelioid-sarcoma/ 2019-07-26T09:34:24+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/Epizyme-Logo.png http://www.pharmajournalist.com/ligand-acquires-ab-initio-biotherapeutics-an-antigen-discovery-company/ 2019-07-26T09:36:38+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Ligand-Pharmaceuticals-logo.png http://www.pharmajournalist.com/acadia-pharmaceuticals-announces-top-line-results-from-phase-3-enhance-trial-of-pimavanserin/ 2019-07-26T09:47:03+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/ACADIA-Pharma-Logo.jpg http://www.pharmajournalist.com/sandoz-announces-first-patient-enrolled-in-clinical-study-for-proposed-biosimilar-denosumab-in-osteoporosis/ 2019-07-26T09:56:25+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/sandoz.jpg http://www.pharmajournalist.com/baxter-announces-fda-approval-of-myxredlin-the-first-and-only-ready-to-use-insulin-for-iv-infusion/ 2019-07-26T09:58:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/baxter.jpg http://www.pharmajournalist.com/zambon-completes-transformational-acquisition-of-breath-therapeutics/ 2019-07-26T10:04:45+00:00 https://pharmajournalist.com/wp-content/uploads/2019/07/zambon-logo.jpg http://www.pharmajournalist.com/biocardia-signs-exclusive-development-agreement-with-astrazeneca/ 2019-07-26T10:06:19+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/biocardia-logo.gif http://www.pharmajournalist.com/aucta-pharmaceuticals-announces-licensing-of-vigabatrin-for-oral-solution-in-china/ 2019-07-26T10:08:20+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Aucta-Pharmaceuticals-Logo.jpg http://www.pharmajournalist.com/regenxbio-expands-pipeline-using-nav-vectors-to-deliver-therapeutic-antibodies-for-the-treatment-of-hereditary-angioedema-and-neurodegenerative-diseases/ 2019-07-26T10:10:31+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/REGENXBIO-logo.png http://www.pharmajournalist.com/uman-diagnostics-and-bio-techne-announce-license-and-supply-agreement-for-neurofilament-light-assay/ 2019-07-26T10:13:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/opiant-expands-partnership-with-sanofi-signs-agreement-for-manufacturing-opnt004-for-treatment-of-acute-cannabinoid-overdose/ 2019-07-26T10:15:28+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/innovation-pharmaceuticals-announces-license-agreement-with-alfasigma/ 2019-07-26T10:18:38+00:00 https://pharmajournalist.com/wp-content/uploads/2019/07/Innovation-Pharma-Logo.png http://www.pharmajournalist.com/avalon-globocare-and-ge-healthcare-announce-strategic-partnership-to-accelerate-standardized-automation-and-bio-production-for-cellular-medicines/ 2019-07-26T10:21:30+00:00 https://pharmajournalist.com/wp-content/uploads/2019/07/Avalon-GloboCare-and-GE-Healthcare.jpg https://pharmajournalist.com/wp-content/uploads/2019/07/Avalon-GloboCare-and-GE-Healthcare.jpg http://www.pharmajournalist.com/lonza-expands-bioconjugation-facility-and-announces-approval-of-third-commercial-adc/ 2019-07-26T10:26:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/lonza.jpg http://www.pharmajournalist.com/contravir-pharmaceuticals-announces-name-change-to-hepion-pharmaceuticals-inc-trading-symbol-change-to-hepa/ 2019-07-26T10:27:59+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/ContraVir-Logo.png http://www.pharmajournalist.com/exclusive-interview-with-astrazenecas-former-vp-medical-evidence-observational-research/ 2019-07-29T14:55:32+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/RWE-Pharma-Journalist-Banners.png http://www.pharmajournalist.com/exclusive-interview-from-conference-speaker-dr-sigbjorn-gregusson-released-ahead-of-smis-9th-annual-biobanking-conference/ 2019-07-31T11:10:17+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/Biobanking-Banner-SMi_Pharma-Journalist.jpg http://www.pharmajournalist.com/pfizer-announces-closing-of-joint-venture-with-glaxosmithkline-to-create-a-premier-global-consumer-healthcare-company/ 2019-08-02T07:54:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/exelixis-and-aurigene-enter-into-exclusive-collaboration/ 2019-08-02T08:05:59+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Exelixis.jpg http://www.pharmajournalist.com/alligator-bioscience-regains-global-rights-from-janssen-to-cd40-agonistic-antibody-adc-1013-jnj-64457107/ 2019-08-02T08:07:47+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/alligator-bioscience-logo.jpg http://www.pharmajournalist.com/fda-approves-bayers-nubeqa-darolutamide-a-new-treatment-for-men-with-non-metastatic-castration-resistant-prostate-cancer/ 2019-08-02T08:13:03+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Bayers-Nubeqa.jpg https://pharmajournalist.com/wp-content/uploads/2019/08/Bayers-Nubeqa.jpg http://www.pharmajournalist.com/lyndra-therapeutics-to-develop-once-monthly-oral-contraceptive/ 2019-08-02T08:16:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/lyndra-inc.jpg http://www.pharmajournalist.com/pfizer-completes-acquisition-of-array-biopharma/ 2019-08-02T08:21:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/sunovion-announces-acceptance-by-fda-of-nda-for-dasotraline-to-treat-binge-eating-disorder/ 2019-08-02T08:23:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/sunovion-logo.jpg http://www.pharmajournalist.com/lillys-verzenio-abemaciclib-significantly-extended-life-in-women-with-hr-her2-advanced-breast-cancer-in-monarch-2/ 2019-08-02T08:26:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/nec-acquires-norwegian-bioinformatics-company-oncoimmunity-as/ 2019-08-02T08:28:17+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/NEC-Corporation-Logo.jpg http://www.pharmajournalist.com/novartis-kisqali-significantly-prolongs-life-in-women-with-hr-her2-advanced-breast-cancer-now-in-two-distinct-phase-iii-trials/ 2019-08-02T08:30:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/merck-to-provide-bioreliance-end-to-end-solutions-to-phanes-therapeutics/ 2019-08-02T08:45:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/pfenex-and-arcellx-announce-a-development-evaluation-and-license-agreement/ 2019-08-02T08:48:00+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Pfenex-Logo.jpg http://www.pharmajournalist.com/marken-acquires-japanese-logistics-company/ 2019-08-02T08:50:36+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Marken-Logo.png http://www.pharmajournalist.com/endo-appoints-domenico-ciarico-as-executive-vice-president-and-chief-commercial-officer-sterile-and-generics/ 2019-08-02T08:52:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/07/endo-logo.png http://www.pharmajournalist.com/neogenomics-announces-grand-opening-of-new-pharma-services-laboratory-in-singapore/ 2019-08-02T08:56:08+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/NeoGenomics-Logo.jpg http://www.pharmajournalist.com/nephron-rapid-micro-announce-first-of-its-kind-automated-microbial-monitoring/ 2019-08-02T08:57:54+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Nephron-Pharma.jpg http://www.pharmajournalist.com/samsung-biologics-and-ucb-sign-third-drug-manufacturing-deal/ 2019-08-02T09:01:03+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Samsung-BioLogics-and-UCB.jpg http://www.pharmajournalist.com/wp-content/uploads/2019/08/Samsung-BioLogics-and-UCB.jpg http://www.pharmajournalist.com/lsne-announces-expansion-of-controlled-temperature-storage-services-at-lsne-bedford/ 2019-08-02T09:02:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/LSNE-Contact-Manufacturing.jpg http://www.pharmajournalist.com/omeros-and-lonza-enter-long-term-manufacturing-agreement-for-commercial-supply-of-narsoplimab/ 2019-08-02T09:04:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/cambrex-to-double-size-of-edinburgh-solid-form-screening-facility/ 2019-08-02T09:07:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/cambrex.jpeg http://www.pharmajournalist.com/alvotech-and-cipla-gulf-enter-into-a-partnership-for-the-commercialization-of-key-biosimilar-in-select-emerging-markets/ 2019-08-02T09:11:06+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Cipla-Logo.png http://www.pharmajournalist.com/niimbl-and-fda-sign-new-agreement-to-support-advanced-innovation-in-biopharmaceutical-manufacturing/ 2019-08-02T09:14:32+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/NIIMBL-Logo.png http://www.pharmajournalist.com/2nd-annual-pharma-packaging-labelling-serialisation-track-and-trace-2019/ 2019-08-05T11:18:24+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/2nd-Pharma-Packaging-2019-300-x-250-px-size-banner-copy.jpg http://www.pharmajournalist.com/big-pharma-are-investing-huge-amounts-in-data-analytics-but-what-are-the-challenges-and-opportunities-of-using-data-infographic-2019-latest-industry-trends/ 2019-08-09T09:16:27+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Data-Analytics-for-Pharma.png http://www.pharmajournalist.com/oric-pharmaceuticals-announces-completion-of-55-million-mezzanine-financing/ 2019-08-09T10:18:18+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Oric-Pharma-Logo.jpg http://www.pharmajournalist.com/dynacure-receives-orphan-drug-designation-from-the-fda-for-dyn101/ 2019-08-09T10:20:22+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/dynacure_logo.png http://www.pharmajournalist.com/new-lung-cancer-treatment-option-approved-by-nice/ 2019-08-09T10:22:41+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Lung-Cancer_NICE.jpg https://pharmajournalist.com/wp-content/uploads/2019/08/Lung-Cancer_NICE.jpg http://www.pharmajournalist.com/takeda-submits-nda-for-a-subcutaneous-formulation-of-vedolizumab-for-patients-with-moderately-to-severely-active-ulcerative-colitis-in-japan/ 2019-08-09T10:24:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/bayer-acquires-bluerock-therapeutics-to-build-leading-position-in-cell-therapy/ 2019-08-09T10:26:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/bayer.jpg http://www.pharmajournalist.com/bayer-and-lanxess-to-sell-their-stakes-in-currenta-to-macquarie-infrastructure-and-real-assets/ 2019-08-09T10:27:25+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/bayer.jpg http://www.pharmajournalist.com/cancer-research-uk-and-hummingbird-bioscience-join-forces-to-advance-novel-antibody-drug-into-clinical-trials/ 2019-08-09T10:29:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/cancer-research-uk.png http://www.pharmajournalist.com/novartis-stands-behind-zolgensma-onasemnogene-abeparvovec-xioi-for-the-treatment-of-children-less-than-2-years-of-age-with-spinal-muscular-atrophy/ 2019-08-09T10:31:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/gsk-grants-exclusive-technology-license-for-clinical-stage-ebola-vaccines-to-sabin-vaccine-institute/ 2019-08-09T10:32:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/stoke-therapeutics-granted-fda-orphan-drug-designation-for-stk-001/ 2019-08-09T10:34:39+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Stoke-Therapeutics-Logo.jpg http://www.pharmajournalist.com/sanofi-dupixent-dupilumab-showed-positive-topline-results-in-phase-3-trial-of-children-aged-6-to-11-years-with-severe-atopic-dermatitis/ 2019-08-09T10:36:33+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/sosei-heptares-and-takeda-enter-into-new-strategic-multi-target-research-development-and-commercialization-partnership/ 2019-08-09T10:41:05+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Sosei_Logo.png http://www.pharmajournalist.com/foamix-submits-nda-to-fda-for-fmx103-for-the-treatment-of-moderate-to-severe-papulopustular-rosacea/ 2019-08-09T10:50:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/fda-approves-daiichi-sankyos-turalio-pexidartinib-for-the-treatment-of-select-patients-with-tgct-a-rare-and-debilitating-tumor/ 2019-08-09T10:55:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/Daiichi-Pharma.jpg http://www.pharmajournalist.com/telix-pharmaceuticals-and-german-cancer-research-center-dkfz-enter-into-collaboration-and-option-agreement-for-image-guided-prostate-surgery/ 2019-08-09T11:01:34+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Partnership.jpg http://www.pharmajournalist.com/neuropore-therapies-and-benevolentai-enter-strategic-collaboration-to-discover-novel-therapeutics-through-the-application-of-artificial-intelligence/ 2019-08-09T11:13:30+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/logo-neuropore.png http://www.pharmajournalist.com/adc-therapeutics-and-sophia-genetics-partner-for-biomarker-discovery-in-pivotal-phase-ii-clinical-trial/ 2019-08-09T11:17:23+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/ADC_Therapeutics_Logo.png http://www.pharmajournalist.com/aquinox-pharmaceuticals-and-neoleukin-therapeutics-announce-merger-agreement/ 2019-08-09T11:19:41+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Aquinox_Logo.png http://www.pharmajournalist.com/vesselon-acquires-fda-approved-lipid-microsphere-drug-imagent-for-therapeutic-platform/ 2019-08-09T11:22:47+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Vesselon_logo.png http://www.pharmajournalist.com/cambrex-to-be-acquired-by-the-permira-funds-for-60-00-per-share-in-cash/ 2019-08-09T11:25:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/alnylam-announces-fda-granted-priority-review-of-the-givosiran-nda-for-the-treatment-of-acute-hepatic-porphyria/ 2019-08-09T11:36:49+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/alnylam-pharmaceuticals_logo.jpg http://www.pharmajournalist.com/hcl-technologies-and-oracle-health-sciences-collaborate-to-accelerate-mhealth-in-clinical-trials/ 2019-08-09T11:42:28+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/HCL-Technologies.png http://www.pharmajournalist.com/lilly-announces-positive-results-for-emgality-galcanezumab-gnlm-from-the-conquer-study-in-patients-who-failed-previous-migraine-preventive-treatments/ 2019-08-09T11:44:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/roches-tecentriq-plus-platinum-based-chemotherapy-improves-pfs-in-bladder-cancer-study/ 2019-08-09T11:46:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/key-opinion-leaders-to-present-at-the-respiratory-drug-delivery-conference/ 2019-08-12T15:04:44+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/300x250.jpg http://www.pharmajournalist.com/fresenius-kabi-will-deliver-two-spotlight-sessions-at-smis-pharmaceutical-manufacturing-cleanroom-technology-conference/ 2019-08-14T07:57:37+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Cleanroom-new-banner.jpg http://www.pharmajournalist.com/discover-the-next-big-thing-in-neuromuscular-therapeutics/ 2019-08-16T08:00:15+00:00 https://pharmajournalist.com/wp-content/uploads/2019/07/Neuromuscular-Drug-Development-Summit-NMD.png http://www.pharmajournalist.com/registration-is-now-open-for-the-pre-filled-syringes-and-injectable-devices-conference-2020/ 2019-08-16T09:56:07+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Pre-Filled-Syringes_Pharma-Journalist.jpg http://www.pharmajournalist.com/harmony-biosciences-announces-fda-approval-of-wakix-pitolisant/ 2019-08-16T10:50:11+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Harmony-Biosciences_Wakix.jpg https://pharmajournalist.com/wp-content/uploads/2019/08/Harmony-Biosciences_Wakix.jpg http://www.pharmajournalist.com/fda-approves-genentechs-tumor-agnostic-medicine-rozlytrek/ 2019-08-16T10:52:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/lynparza-phase-iii-paola-1-trial-met-primary-endpoint-as-1st-line-maintenance-treatment-with-bevacizumab-for-advanced-ovarian-cancer/ 2019-08-16T10:54:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/curevac-enters-into-an-exclusive-collaborative-research-agreement-for-discovery-research-in-mrna-based-lung-therapy-candidates-with-yale-university/ 2019-08-16T10:57:27+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Curevac-logo.png http://www.pharmajournalist.com/calquence-granted-us-breakthrough-therapy-designation-for-chronic-lymphocytic-leukaemia/ 2019-08-16T10:59:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/boehringer-and-md-anderson-form-unique-virtual-research-and-development-center-to-rapidly-advance-new-cancer-therapies/ 2019-08-16T11:01:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/jazz-pharmaceuticals-announces-acquisition-of-cavion-inc/ 2019-08-16T11:02:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/jazz-pharmaceuticals.jpg http://www.pharmajournalist.com/sonnet-biotherapeutics-agrees-to-buy-relief-therapeutics/ 2019-08-16T11:05:34+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Relief-Therapeutics-Logo.png http://www.pharmajournalist.com/amgen-wins-patent-case-on-enbrel-etanercept/ 2019-08-16T11:07:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg http://www.pharmajournalist.com/phio-pharmaceuticals-and-helmholtz-zentrum-munchen-to-collaborate-on-novel-targets/ 2019-08-16T11:10:22+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Phio-Pharmaceuticals-Logo.png http://www.pharmajournalist.com/genecentric-therapeutics-acquires-select-immunogenomics/ 2019-08-16T11:12:16+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/GeneCentric-Logo.png http://www.pharmajournalist.com/askbio-acquires-synpromics-and-expands-its-gene-therapy-technology-portfolio/ 2019-08-16T11:14:13+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/askbi-Logo.jpg http://www.pharmajournalist.com/oncologie-announces-clinical-trial-collaboration-with-merck-to-evaluate-bavituximab-in-combination-with-keytruda-pembrolizumab/ 2019-08-16T11:16:42+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Oncologie-Logo.png http://www.pharmajournalist.com/onconova-therapeutics-and-mission-bio-partner-to-advance-precision-oncology-clinical-trials-employing-single-cell-genomics/ 2019-08-16T11:19:14+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Onconova-Therapeutics-Logo.png http://www.pharmajournalist.com/ema-validates-marketing-application-for-filgotinib-for-the-treatment-of-rheumatoid-arthritis/ 2019-08-16T11:21:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/lilly-announces-superiority-of-taltz-versus-tremfya-in-ixora-r-trial/ 2019-08-16T11:23:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/janssen-announces-european-commission-approval-of-imbruvica-ibrutinib-for-expanded-use-in-two-indications/ 2019-08-16T11:25:16+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Janssen-Pharma-Logo.jpg http://www.pharmajournalist.com/eidos-therapeutics-confirms-receipt-of-non-binding-proposal-from-bridgebio-pharma-to-acquire-shares/ 2019-08-16T11:29:08+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/eidos-logo.png http://www.pharmajournalist.com/ascletis-opens-clinical-development-shanghai-center/ 2019-08-16T11:31:02+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/ascletis-logo.jpg http://www.pharmajournalist.com/neoleukin-therapeutics-and-aquinox-pharmaceuticals-complete-merger-transaction/ 2019-08-16T11:35:33+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/neoleukin-logo.jpg http://www.pharmajournalist.com/fda-approves-new-drug-for-treatment-resistant-forms-of-tuberculosis-that-affects-the-lungs/ 2019-08-16T11:36:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/syapse-announces-research-collaboration-with-the-fda-focused-on-the-regulatory-use-of-real-world-evidence/ 2019-08-16T11:38:35+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Syapse-Logo.png http://www.pharmajournalist.com/regulatory-and-policy-keynote-sessions-to-be-delivered-at-the-wearable-injectors-and-connected-devices-conference/ 2019-08-21T05:37:01+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/300x250.jpg http://www.pharmajournalist.com/four-key-reasons-to-attend-the-2019-biosimilars-conference/ 2019-08-22T08:54:11+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/P-298-Biosimilars-300x250.jpg http://www.pharmajournalist.com/pfizer-invests-half-billion-dollars-to-advance-state-of-the-art-gene-therapy-facility-in-sanford-north-carolina/ 2019-08-23T08:23:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/roxadustat-approved-in-china-for-the-treatment-of-anaemia-in-non-dialysis-dependent-patients-with-ckd/ 2019-08-23T08:32:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/fda-grants-xtandi-enzalutamide-application-priority-review-for-the-treatment-of-men-with-metastatic-hormone-sensitive-prostate-cancer/ 2019-08-23T08:35:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/astrazeneca-agrees-to-buy-us-fda-priority-review-voucher-from-sobi/ 2019-08-23T08:38:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/farxiga-met-primary-endpoint-in-landmark-phase-iii-dapa-hf-trial-for-the-treatment-of-patients-with-heart-failure/ 2019-08-23T08:40:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astrazeneca.jpg http://www.pharmajournalist.com/sarepta-therapeutics-receives-complete-response-letter-from-the-fda-for-golodirsen-new-drug-application/ 2019-08-23T08:42:23+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/Sarepta-Therapeutics.jpg http://www.pharmajournalist.com/bayer-to-sell-its-animal-health-business-unit-to-elanco-for-7-6-billion-u-s-dollars/ 2019-08-23T08:45:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/bayer.jpg http://www.pharmajournalist.com/vaxxilon-awarded-carb-x-grant-to-advance-novel-prophylactic-vaccine-to-prevent-klebsiella-pneumoniae-infections/ 2019-08-23T08:48:32+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Vaxxilon-Logo.png http://www.pharmajournalist.com/mateon-and-pointr-to-merge-into-ai-driven-oncology-firm/ 2019-08-23T08:50:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/nabriva-therapeutics-receives-fda-approval-of-xenleta-lefamulin-to-treat-cabp/ 2019-08-23T08:53:14+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/xenleta-vial-bottle-carton-tablets-003.jpg https://pharmajournalist.com/wp-content/uploads/2019/08/xenleta-vial-bottle-carton-tablets-003.jpg http://www.pharmajournalist.com/juvenescence-closes-100m-series-b-round-for-longevity-therapies/ 2019-08-23T08:57:46+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Juvenescence-Logo.png http://www.pharmajournalist.com/gsk-submits-first-regulatory-application-for-daprodustat-in-japan/ 2019-08-23T09:00:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/fda-accepts-new-drug-application-for-vx-445-elexacaftor-tezacaftor-and-ivacaftor-combination-treatment/ 2019-08-23T09:02:22+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Vertex.jpg http://www.pharmajournalist.com/moderna-receives-fda-fast-track-designation-for-zika-vaccine-mrna-1893/ 2019-08-23T09:05:34+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Moderna-Logo.png http://www.pharmajournalist.com/iconic-therapeutics-signs-ophthalmology-option-agreement/ 2019-08-23T09:08:47+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Iconic-Therapeutics-Logo.jpg http://www.pharmajournalist.com/enable-injections-enters-into-strategic-partnership-with-genentech-a-member-of-the-roche-group/ 2019-08-23T09:10:40+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/enable-injections-logo.png http://www.pharmajournalist.com/innovent-enters-a-licensing-agreement-with-lilly-to-develop-commercialize-a-novel-diabetes-medicine-in-china/ 2019-08-23T09:21:31+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/innovent-biologics-logo.png http://www.pharmajournalist.com/enteris-biopharma-and-cara-therapeutics-enter-into-licensing-agreement-for-peptelligence-to-advance-development-of-oral-korsuva/ 2019-08-23T09:25:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/tonix-pharma-expands-preclinical-pipeline-with-triple-reuptake-inhibitor-tnx-1600-for-the-treatment-of-ptsd/ 2019-08-23T09:28:27+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Tonix_Logo.png http://www.pharmajournalist.com/emendo-biotherapeutics-achieves-milestone-of-collaboration-with-takeda-for-its-omni-nuclease-program/ 2019-08-23T09:31:23+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/emendo-logo.png http://www.pharmajournalist.com/alligator-bioscience-signs-antibody-agreement-for-greater-china-with-biotheus/ 2019-08-23T09:34:25+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/alligator-bioscience-logo.jpg http://www.pharmajournalist.com/eag-laboratories-launches-new-laboratory-in-china/ 2019-08-23T09:39:27+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Eag-Lab-Logo.png http://www.pharmajournalist.com/ibio-inks-3d-bioprinting-agreement/ 2019-08-23T09:41:35+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/ibio-logo.jpg http://www.pharmajournalist.com/fda-approves-new-antibiotic-to-treat-community-acquired-bacterial-pneumonia/ 2019-08-23T09:44:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/miracor-medical-granted-fda-breakthrough-device-designation-for-the-picso-impulse-system/ 2019-08-23T09:48:39+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/miracor-medical-logo.png http://www.pharmajournalist.com/workshop-speakers-laurent-dolle-bwb-and-mary-beth-joshi-biobank-announced-for-the-9th-annual-conference-on-biobanking/ 2019-08-27T11:13:35+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/Biobanking-Banner-SMi_Pharma-Journalist.jpg http://www.pharmajournalist.com/exclusive-sanofi-rd-speaker-interview-released-for-5th-lyophilization-usa-conference/ 2019-08-27T11:29:04+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/Lyophilization-USA-2019_Banner_Pharma-Journalist.jpg http://www.pharmajournalist.com/new-technologies-for-hpapi-manufacturing-and-containment/ 2019-08-29T09:10:33+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/300x250-copy.jpg http://www.pharmajournalist.com/anifrolumab-phase-iii-trial-meets-primary-endpoint-in-systemic-lupus-erythematosus/ 2019-08-30T11:33:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/fda-approves-new-add-on-drug-to-treat-off-episodes-in-adults-with-parkinsons-disease/ 2019-08-30T11:35:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/lannett-enters-into-distribution-agreement-for-posaconazole-delayed-release-tablets-launch-to-commence-shortly/ 2019-08-30T11:36:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/lannett-logo.jpg http://www.pharmajournalist.com/ec-approves-roches-tecentriq-in-combination-with-abraxane-for-people-with-pd-l1-positive-metastatic-triple-negative-breast-cancer/ 2019-08-30T11:38:28+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/fda-grants-fast-track-designation-for-farxiga-in-chronic-kidney-disease/ 2019-08-30T11:40:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astrazeneca.jpg http://www.pharmajournalist.com/ec-approves-bristol-myers-squibbs-empliciti-to-treat-multiple-myeloma/ 2019-08-30T11:43:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/fasenra-granted-us-orphan-drug-designation-for-eosinophilic-oesophagitis/ 2019-08-30T13:33:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astrazeneca.jpg http://www.pharmajournalist.com/hifibio-therapeutics-closes-55m-series-c-financing/ 2019-08-30T13:35:44+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/HiFiBiO-Logo.png http://www.pharmajournalist.com/immatics-and-celgene-enter-strategic-collaboration-to-develop-novel-adoptive-cell-therapies/ 2019-08-30T13:38:38+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/immatics-logo.jpg http://www.pharmajournalist.com/zogenix-announces-acquisition-of-modis-therapeutics-inc/ 2019-08-30T13:42:26+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/zgnx.png http://www.pharmajournalist.com/johnson-johnson-to-appeal-flawed-opioid-judgment-in-oklahoma/ 2019-08-30T13:44:25+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Johnson-Johnson-Logo.png http://www.pharmajournalist.com/adc-therapeutics-and-freenome-enter-biomarker-development-collaboration/ 2019-08-30T13:45:54+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/ADC_Therapeutics_Logo.png http://www.pharmajournalist.com/la-jolla-pharmaceutical-company-receives-european-commission-approval-for-giapreza-angiotensin-ii/ 2019-08-30T13:49:44+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/LaJolla_Logo.png http://www.pharmajournalist.com/adaptimmune-and-noile-immune-announce-agreement-to-develop-spear-t-cell-products-expressing-il-7-and-ccl19-as-a-next-generation-treatment-for-cancer-patients/ 2019-08-30T13:51:27+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Adaptimmune-Therapeutics-logo.png http://www.pharmajournalist.com/machavert-pharma-signs-exclusive-license-agreement-to-control-ral-gtpase-inhibitors-against-kras-cancers/ 2019-08-30T13:53:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/abbvie-discontinues-rovalpituzumab-tesirine-rova-t-research-and-development-program/ 2019-08-30T13:57:25+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/esperions-bempedoic-acid-ezetimibe-tablet-achieves-positive-phase-ii-results/ 2019-08-30T14:00:07+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/esperion-logo-primary.png http://www.pharmajournalist.com/ajinomoto-bio-pharma-services-acquires-remaining-interest-in-granules-omnichem-joint-venture-in-india/ 2019-08-30T14:02:36+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Ajinomoto-Bio-Pharma.jpg http://www.pharmajournalist.com/pci-strengthens-position-in-europe-with-investment-in-ireland/ 2019-08-30T14:04:00+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/PCI-Cold-Chain-Infra.jpg http://www.pharmajournalist.com/alvotech-and-prestige-biopharma-announce-new-manufacturing-partnership/ 2019-08-30T14:06:24+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/alvotech-facility.jpg http://www.pharmajournalist.com/ionis-licenses-hepatitis-b-program-to-gsk/ 2019-08-30T14:10:08+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Ionis-Logo.png http://www.pharmajournalist.com/viralgen-receives-cgmp-certification-from-european-medicines-agency/ 2019-08-30T14:12:53+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Viralgen-Logo.jpg http://www.pharmajournalist.com/mustang-bio-csl-behring-enter-license-agreement-for-stable-producer-cell-line/ 2019-08-30T14:15:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/mustang-bio-logo.jpg http://www.pharmajournalist.com/wcg-introduces-velos-eresearch-express/ 2019-08-30T14:17:19+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/WCG-Logo.jpg http://www.pharmajournalist.com/rna-targeted-small-molecules-finally-drug-the-undruggable-rna/ 2019-09-02T08:56:46+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/RNA-TDD-Pharma-Journalist-Banner.png http://www.pharmajournalist.com/2nd-annual-pharma-packaging-labelling-serialisation-track-and-trace-2019-2/ 2019-09-03T10:12:00+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/2nd-Pharma-Packaging-2019-300-x-250-px-size-banner-copy.jpg http://www.pharmajournalist.com/an-exclusive-aerie-pharmaceuticals-speaker-interview-released-for-smis-ophthalmic-drugs-conference-2019/ 2019-09-04T08:00:21+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Ophthalmic-Drugs.jpg http://www.pharmajournalist.com/learn-about-technological-innovations-at-smis-pre-filled-syringes-workshop-day/ 2019-09-04T12:49:43+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Pre-Filled-Syringes_Pharma-Journalist.jpg http://www.pharmajournalist.com/biomotiv-and-bristol-myers-squibb-form-strategic-partnership/ 2019-09-06T08:43:45+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/BioMotiv-Logo.jpg http://www.pharmajournalist.com/boehringer-expands-kras-cancer-program-with-lupins-clinical-stage-mek-inhibitor-compound/ 2019-09-06T08:45:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/tagrisso-approved-in-china-as-a-1st-line-treatment-for-egfr-mutated-non-small-cell-lung-cancer/ 2019-09-06T08:47:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/nice-recommends-novel-gene-therapy-treatment-for-rare-inherited-eye-disorder/ 2019-09-06T08:49:45+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/Young-boy-has-eye-examination.jpg http://www.pharmajournalist.com/vertex-to-acquire-semma-therapeutics-with-a-goal-of-developing-curative-cell-based-treatments-for-type-1-diabetes/ 2019-09-06T08:51:40+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Vertex.jpg http://www.pharmajournalist.com/cidara-therapeutics-and-mundipharma-form-strategic-partnership-to-develop-and-commercialize-rezafungin/ 2019-09-06T08:55:15+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/CIDARA-THERAPEUTICS.png http://www.pharmajournalist.com/achilles-therapeutics-raises-100-million-in-oversubscribed-series-b-financing/ 2019-09-06T08:59:47+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/Achilles-Therapeutics.jpg http://www.pharmajournalist.com/sandoz-announces-global-deal-to-commercialize-proposed-biosimilar-natalizumab-a-key-multiple-sclerosis-medicine/ 2019-09-06T09:03:25+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/sandoz.jpg http://www.pharmajournalist.com/novartis-paragon-hf-trial-suggests-entresto-benefit-in-hfpef-patients-but-narrowly-misses-primary-endpoint/ 2019-09-06T09:09:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/impel-neuropharma-announces-last-patient-enrolled-in-phase-3-trial-evaluating-inp104-for-the-treatment-of-acute-migraine/ 2019-09-06T09:56:02+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/Impel-Logo.jpg http://www.pharmajournalist.com/allergan-receives-fda-approval-of-juvederm-voluma-xc-for-mid-face-injection-via-cannula/ 2019-09-06T09:57:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/allergan.jpg http://www.pharmajournalist.com/entresto-improved-measures-of-heart-structure-and-function-in-hfref-patients-in-new-novartis-study-additional-data-complement-findings/ 2019-09-06T10:02:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/roche-presents-positive-phase-iii-study-results-for-one-dose-xofluza-in-children-with-flu/ 2019-09-06T10:07:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/american-brivision-announces-strategic-collaboration-with-biolite-japan/ 2019-09-06T10:26:48+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Partnership.jpg http://www.pharmajournalist.com/valo-therapeutics-acquires-peptienv-technology-from-the-university-of-helsinki/ 2019-09-06T10:30:54+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/Valo-Therapeutics-Logo.jpg http://www.pharmajournalist.com/helsinn-signs-exclusive-distribution-and-license-agreements-with-blanver-and-varifarma-for-pracinostat-in-south-america/ 2019-09-06T10:33:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/schrodinger-announces-collaboration-with-astrazeneca-to-deploy-advanced-computing-technology-for-drug-discovery/ 2019-09-06T10:34:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astrazeneca.jpg http://www.pharmajournalist.com/covance-launches-laboratory-data-management-functional-service-provider-for-pharmaceutical-and-biotechnology-customers/ 2019-09-06T10:40:01+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/LabCorp-Logo.jpg http://www.pharmajournalist.com/biomx-announces-in-house-phage-manufacturing-facility/ 2019-09-06T10:42:49+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/biomxlogo.png http://www.pharmajournalist.com/ppds-accelerated-enrollment-solutions-acquires-global-site-business-from-bioclinica/ 2019-09-06T11:01:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/PPD-office_wikipedia.jpg http://www.pharmajournalist.com/zyversa-therapeutics-to-advance-development-of-its-lead-inflammasome-inhibitor-with-selexis-and-kbi-biopharmas-integrated-development-platform/ 2019-09-06T11:05:51+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/Zyversa-Logo.jpg http://www.pharmajournalist.com/celltrion-and-lonza-sign-contract-to-manufacture-remsima-drug-substance/ 2019-09-06T11:07:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/lonza.jpg http://www.pharmajournalist.com/mike-page-alexion-pharmaceuticals-invite-to-smis-orphan-drugs-rare-diseases-conference/ 2019-09-06T11:16:48+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/300x250-P-300-.jpg http://www.pharmajournalist.com/calling-all-pharma-cleanroom-experts-join-us-in-london-the-worlds-top-destination-to-visit/ 2019-09-12T16:22:36+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Cleanroom-new-banner.jpg http://www.pharmajournalist.com/nucala-is-the-first-biologic-approved-in-the-us-for-six-to-11-year-old-children-with-severe-eosinophilic-asthma/ 2019-09-13T10:28:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/vertex-announces-new-access-agreement-with-scottish-government-for-orkambi-lumacaftor-ivacaftor-and-symkevi-tezacaftor-ivacaftor/ 2019-09-13T10:30:10+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Vertex.jpg http://www.pharmajournalist.com/mallinckrodt-agrees-to-sell-biovectra-inc-to-h-i-g-capital-for-250-million/ 2019-09-13T10:33:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/mallinckrodt-pharma.jpg http://www.pharmajournalist.com/avalon-ventures-and-coi-pharmaceuticals-announce-acquisition-of-sitari-pharmaceuticals-by-gsk/ 2019-09-13T10:34:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/fda-approves-first-treatment-for-patients-with-rare-type-of-lung-disease/ 2019-09-13T10:37:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/flexion-therapeutics-licences-pain-therapy-from-xenon-pharmaceuticals/ 2019-09-13T10:38:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/flexion-therapeutics-logo.png http://www.pharmajournalist.com/genmab-and-tempus-enter-into-strategic-collaboration-agreement/ 2019-09-13T10:40:22+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Genmab-Logo.jpg http://www.pharmajournalist.com/roche-secures-two-ec-approvals-for-tecentriq-in-lung-cancer/ 2019-09-13T10:43:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/aytu-bioscience-announces-definitive-agreement-to-acquire-innovus-pharmaceuticals/ 2019-09-13T10:46:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/aytu-bioscience-logo.png http://www.pharmajournalist.com/hansoh-pharma-and-atomwise-launch-strategic-ai-drug-discovery-collaboration-for-multiple-therapeutic-areas/ 2019-09-13T10:49:41+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/hansoh-pharma-logo.jpg http://www.pharmajournalist.com/xeris-pharmaceuticals-receives-fda-approval-for-gvoke-glucagon/ 2019-09-13T10:54:38+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/Xeris-Logo.jpg http://www.pharmajournalist.com/horizon-secures-fda-priority-review-for-teprotumumab-for-treatment-of-active-thyroid-eye-disease/ 2019-09-13T11:04:50+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/Horizon-Therapeutics-Logo.jpg http://www.pharmajournalist.com/esketamine-nasal-spray-reduces-depressive-symptoms-in-two-phase-3-studies/ 2019-09-13T11:12:06+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Johnson-Johnson-Logo.png http://www.pharmajournalist.com/ridgeback-biotherapeutics-lp-announces-receipt-of-breakthrough-therapy-designation-from-fda-for-mab114/ 2019-09-13T11:26:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/thermo-fisher-scientific-signs-agreement-with-lilly-oncology-for-companion-diagnostic-to-be-used-with-ret-inhibitor/ 2019-09-13T11:27:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/thermo-fisher-scientific.jpg http://www.pharmajournalist.com/i-mab-biopharma-and-junshi-biosciences-announce-collaboration-to-evaluate-tjd5-in-combination-with-toripalimab/ 2019-09-13T11:40:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/dance-biopharm-partners-with-dariohealth-to-expand-access-to-digital-therapeutics-platform-for-patients-with-chronic-diseases/ 2019-09-13T11:44:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/castle-creek-pharmaceutical-holdings-announces-agreement-to-acquire-fibrocell/ 2019-09-13T11:46:15+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Partnership.jpg http://www.pharmajournalist.com/q-biomed-and-collaborator-chemveda-life-sciences-enter-agreement-for-synthesis-and-manufacturing-of-liver-cancer-chemotherapeutic/ 2019-09-13T11:52:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/sharp-expands-its-clinical-operations-to-european-facility/ 2019-09-13T11:54:16+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/Heerenveen-The-Netherlands.png http://www.pharmajournalist.com/fda-extends-crada-with-cluepoints-to-further-explore-a-data-driven-approach-to-quality-oversight-in-clinical-trials/ 2019-09-13T11:55:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/fujifilm-irvine-scientific-launches-balancd-gal-supplement-for-biotherapeutic-development/ 2019-09-13T11:58:38+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/Irvine-Scientific-Logo.png http://www.pharmajournalist.com/cmab-biopharma-receives-positive-opinion-following-external-quality-audit/ 2019-09-13T12:00:51+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/CMAB-Logo.jpg http://www.pharmajournalist.com/irbm-signs-agreement-with-md-anderson-cancer-center-to-generate-novel-immune-checkpoint-monoclonal-antibodies/ 2019-09-13T12:02:25+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/IRBM.png http://www.pharmajournalist.com/citryll-and-lonza-enter-into-partnership-to-manufacture-netosis-inhibiting-antibody-cit-013/ 2019-09-13T12:03:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/lonza.jpg http://www.pharmajournalist.com/only-two-weeks-left-until-the-biobanking-2019-conference-in-london/ 2019-09-17T07:17:44+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/Biobanking-Banner-SMi_Pharma-Journalist.jpg http://www.pharmajournalist.com/exclusive-interview-with-novartis-industry-leader-maxime-gaillot-for-the-wearable-injectors-and-connected-devices-conference-2019-in-london/ 2019-09-17T10:59:02+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/300x250.jpg http://www.pharmajournalist.com/sanbio-granted-regenerative-medicine-advanced-therapy-designation-from-fda-for-sb623/ 2019-09-20T08:57:46+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/SanBio-Logo.png http://www.pharmajournalist.com/takeda-and-lundbeck-announce-ministry-of-health-labour-and-welfare-mhlw-approval-of-trintellix-in-japan/ 2019-09-20T09:01:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/versantis-closes-chf-16m-series-b-financing-round-to-advance-clinical-development-of-novel-therapeutics-for-liver-diseases/ 2019-09-20T09:05:55+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/Versantis_Logo.jpg http://www.pharmajournalist.com/astrazeneca-amends-collaboration-with-ironwood-for-linzess-in-china/ 2019-09-20T09:09:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/fda-grants-breakthrough-therapy-designation-for-roches-gazyva-obinutuzumab-in-lupus-nephritis/ 2019-09-20T09:10:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/oncoheroes-and-boehringer-sign-exclusive-licensing-agreement-for-volasertib/ 2019-09-20T09:16:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/fda-accepts-mercks-bla-and-grants-priority-review-for-v920-the-companys-investigational-vaccine-for-ebola-zaire-virus/ 2019-09-20T09:19:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/fda-grants-fast-track-designation-for-farxiga-in-heart-failure/ 2019-09-20T09:22:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/lundbeck-to-acquire-alder-biopharmaceuticals/ 2019-09-20T09:23:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/lundbeck-logo.jpg http://www.pharmajournalist.com/amplyx-pharmaceuticals-licenses-phase-2-drug-candidate-for-bk-viral-disease-in-transplant-patients/ 2019-09-20T09:29:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/eisai-and-biogen-to-discontinue-phase-iii-clinical-studies-of-bace-inhibitor-elenbecestat-in-early-alzheimers-disease/ 2019-09-20T09:31:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/eisai-logo.jpg http://www.pharmajournalist.com/fda-approves-keytruda-plus-lenvima-for-endometrial-carcinoma/ 2019-09-20T09:32:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/novartis-cosentyx-positive-16-week-prevent-results-advance-potential-new-indication-for-patients-with-axial-spondyloarthritis/ 2019-09-20T09:34:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/concert-pharmaceuticals-completes-enrollment-in-second-open-label-trial-of-ctp-543-in-alopecia-areata/ 2019-09-20T09:36:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/concert-pharmaceuticals.jpg http://www.pharmajournalist.com/poxel-initiates-phase-1b-multiple-ascending-dose-mad-trial-for-nash-drug-candidate-pxl065/ 2019-09-20T09:54:09+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/poxel-logo.png http://www.pharmajournalist.com/alnylam-announces-initiation-of-apollo-b-phase-3-study-of-patisiran-for-the-treatment-of-transthyretin-amyloidosis-with-cardiomyopathy/ 2019-09-20T09:59:22+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/alnylam-pharmaceuticals_logo.jpg http://www.pharmajournalist.com/accenture-announces-collaboration-with-bayer-to-streamline-drug-development-processes-through-intient-clinical-platform/ 2019-09-20T10:02:03+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/accenture.jpg http://www.pharmajournalist.com/y-trap-enters-collaboration-with-merck-kgaa-darmstadt-germany-to-develop-novel-antibody-ligand-traps-for-immuno-oncology/ 2019-09-20T10:05:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/allogene-therapeutics-enters-research-collaboration-directed-at-enhancing-future-cancer-immunotherapies/ 2019-09-20T10:08:04+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/Allogene-Therapeutics-Logo.png http://www.pharmajournalist.com/bioxcel-therapeutics-announces-bxcl501-program-initiative-for-prevention-and-treatment-of-acute-agitation-using-wearable-digital-devices/ 2019-09-20T10:10:24+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/bioxcel-therapeutics-logo.png http://www.pharmajournalist.com/ibios-collaboration-with-south-africas-azargen-biotechnologies-advances-to-next-stage/ 2019-09-20T10:12:55+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/iBio-Logo.jpg http://www.pharmajournalist.com/bioq-pharma-announces-partnership-with-avanos-medical/ 2019-09-20T10:17:02+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/BioQ-Pharma-Logo.jpg http://www.pharmajournalist.com/alivamab-discovery-services-announces-multi-target-agreement-with-janssen/ 2019-09-20T10:19:33+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/AlivaMab-logo.png http://www.pharmajournalist.com/akari-therapeutics-nomacopan-granted-u-s-orphan-drug-designation-for-bullous-pemphigoid/ 2019-09-20T10:21:53+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/Akari-Therapeutics-Logo.png http://www.pharmajournalist.com/chairs-post-an-invitation-letter-for-the-12th-annual-pre-filled-syringes-and-injectable-drugs-conference/ 2019-09-23T12:06:44+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Pre-Filled-Syringes_Pharma-Journalist.jpg http://www.pharmajournalist.com/leading-microbiologists-to-meet-at-smis-9th-annual-pharmaceutical-microbiology-confex/ 2019-09-24T07:26:16+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/Pharma-Micro-UK-300x250.jpg http://www.pharmajournalist.com/device-advancements-to-be-discussed-at-the-respiratory-drug-delivery-conference-2019/ 2019-09-24T10:21:48+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/300x250.jpg http://www.pharmajournalist.com/europes-top-pharma-marketing-leaders-set-to-meet-in-london-next-month/ 2019-09-25T07:13:26+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/Marketing-Customer-Innovation.png http://www.pharmajournalist.com/an-exclusive-speaker-interview-with-twoxar-ceo-for-smis-3rd-annual-ophthalmic-drugs-conference-2019/ 2019-09-27T08:17:29+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Ophthalmic-Drugs.jpg http://www.pharmajournalist.com/top-3-reasons-to-attend-the-hpapi-usa-conference-2019/ 2019-09-27T08:22:23+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/300x250-copy.jpg http://www.pharmajournalist.com/achillion-receives-breakthrough-therapy-designation-from-fda-for-danicopan-for-treatment-of-pnh/ 2019-09-27T08:26:22+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/Achillion-Logo.png http://www.pharmajournalist.com/european-commission-grants-orphan-drug-designation-for-nirogacestat-for-the-treatment-of-soft-tissue-sarcoma/ 2019-09-27T08:28:36+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/SpringWorks-Therapeutics.jpg http://www.pharmajournalist.com/evotec-and-takeda-enter-collaboration-agreement-to-discover-clinical-candidates-across-multiple-therapeutic-areas/ 2019-09-27T08:31:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/fda-approves-first-live-non-replicating-vaccine-to-prevent-smallpox-and-monkeypox/ 2019-09-27T08:33:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/qtrilmet-recommended-for-approval-in-eu-by-chmp-for-the-treatment-of-type-2-diabetes/ 2019-09-27T08:35:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/proteon-therapeutics-and-artara-therapeutics-agree-to-combine/ 2019-09-27T08:37:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/proteon-therapeutics-logo.png http://www.pharmajournalist.com/boehringer-partners-with-inflammasome-therapeutics-to-develop-novel-therapies-for-patients-with-retinal-diseases/ 2019-09-27T08:40:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Boehringer-Ingelheim.jpg http://www.pharmajournalist.com/blade-therapeutics-expands-anti-fibrotic-pipeline-with-acquisition-of-atxco-and-its-autotaxin-inhibitor-pat-409/ 2019-09-27T08:51:49+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/Blade-Therapeutics-Logo.jpg http://www.pharmajournalist.com/exclusive-bionical-emas-speaker-interview-released-for-the-orphan-drugs-rare-diseases-conference/ 2019-09-27T08:54:14+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/300x250-P-300-.jpg http://www.pharmajournalist.com/aldeyra-therapeutics-receives-fast-track-designation-for-adx-2191-for-the-prevention-of-proliferative-vitreoretinopathy/ 2019-09-27T08:58:32+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/aldeyra-logo.png http://www.pharmajournalist.com/zealand-pharma-achieves-primary-and-all-key-secondary-endpoints-in-pediatric-phase-3-trial-with-dasiglucagon-for-severe-hypoglycemia/ 2019-09-27T09:03:43+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/zealand-logo.jpg http://www.pharmajournalist.com/clovis-oncology-acquires-rights-to-fap-targeted-radiopharmaceutical-program-from-3b-pharmaceuticals/ 2019-09-27T09:06:00+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/Clovis-Oncology-Logo.png http://www.pharmajournalist.com/pfizer-and-flatiron-health-announce-expanded-strategic-collaboration-to-unlock-power-of-rwe-in-oncology/ 2019-09-27T09:07:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/i-mab-biopharma-announces-clinical-collaboration-to-evaluate-tjc4-in-combination-with-keytruda-pembrolizumab/ 2019-09-27T09:17:02+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/I-MAB-Biopharma-Logo.jpg http://www.pharmajournalist.com/immunoprecises-talem-therapeutics-enters-into-an-loi-with-agonox-pharma-in-the-advancement-of-novel-immuno-oncology-therapeutics/ 2019-09-27T09:19:36+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/Immunoprecise-Logo.jpg http://www.pharmajournalist.com/neucyte-licenses-promising-novel-compound-for-treatment-of-refractory-epilepsy-and-related-neurological-disorders/ 2019-09-27T09:21:36+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/Neucyte-Logo.jpg http://www.pharmajournalist.com/moderna-announces-mrna-immunotherapy-research-collaboration-with-harvard-university/ 2019-09-27T09:23:31+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Moderna-Logo.png http://www.pharmajournalist.com/cryoport-introduces-cell-gene-industrys-first-dedicated-shipper-for-advanced-therapies/ 2019-09-27T09:26:13+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Cryoport-Logo.jpg http://www.pharmajournalist.com/catalent-and-minerva-neurosciences-enter-commercial-supply-agreement-for-schizophrenia-drug-roluperidone/ 2019-09-27T09:30:56+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Catalent-Logo.png http://www.pharmajournalist.com/hovione-announces-successful-end-of-phase-2-meeting-with-the-fda-and-outlines-phase-3-program-for-minocycline-topical-gel/ 2019-09-27T09:34:20+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/Hovione-Logo.jpg http://www.pharmajournalist.com/pii-to-manufacture-fda-approved-hormone-therapy-injection-drug-product/ 2019-09-27T09:35:36+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/Pii-Logo.jpg http://www.pharmajournalist.com/pci-unveils-clinical-center-of-excellence/ 2019-09-27T09:37:03+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/PCI-Cold-Chain-Infra.jpg http://www.pharmajournalist.com/ppd-expanding-bioanalytical-laboratory-capabilities/ 2019-09-27T09:38:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/PPD-office_wikipedia.jpg http://www.pharmajournalist.com/registration-is-now-open-for-smis-14th-annual-parallel-trade-conference-2020/ 2019-10-02T08:35:50+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Parallel-Trade-2020.jpg http://www.pharmajournalist.com/mercks-keytruda-pembrolizumab-now-approved-as-monotherapy-in-china-for-nsclc/ 2019-10-04T08:09:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/servier-acquires-non-hodgkin-b-cell-lymphoma-treatment-pixuvri-pixantrone-from-cti-biopharma/ 2019-10-04T08:27:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Servier-CDMO.png http://www.pharmajournalist.com/novartis-and-microsoft-announce-collaboration-to-transform-medicine-with-artificial-intelligence/ 2019-10-04T08:28:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/fda-approves-roches-rituxan-rituximab-in-children-with-two-rare-blood-vessel-disorders/ 2019-10-04T08:31:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/sobi-to-acquire-dova-pharmaceuticals-creating-a-global-growth-platform-in-haematology/ 2019-10-04T08:35:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/sobi.png http://www.pharmajournalist.com/moberg-pharma-and-taisho-sign-exclusive-license-agreement-for-mob-015-in-japan/ 2019-10-04T08:37:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/fasenra-approved-in-the-us-for-self-administration-in-a-new-pre-filled-auto-injector-the-fasenra-pen/ 2019-10-04T08:39:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/kinoxis-therapeutics-awarded-nih-heal-initiative-grant-to-advance-knx100-for-the-treatment-of-opioid-withdrawal/ 2019-10-04T08:42:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/drug-discovery.jpg http://www.pharmajournalist.com/elicio-therapeutics-completes-33-million-series-b-financing/ 2019-10-04T08:55:13+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/elicio-therapeutics-logo.jpg http://www.pharmajournalist.com/lantheus-to-acquire-progenics-to-form-a-leading-precision-diagnostics-imaging-and-therapeutics-company/ 2019-10-04T09:06:17+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Lantheus-Holding-Logo.jpg http://www.pharmajournalist.com/gsk-submits-filing-to-fda-for-trelegy-ellipta-use-in-patients-with-asthma/ 2019-10-04T09:09:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/clover-biopharmaceuticals-doses-first-patient-in-phase-i-study-of-scb-313-in-china-for-malignant-ascites/ 2019-10-04T09:12:14+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Clover-Biopharmaceuticals-Logo.jpg http://www.pharmajournalist.com/currax-pharmaceuticals-announces-the-acquisition-of-nalpropion-pharmaceuticals/ 2019-10-04T09:20:06+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/currax-logo.png http://www.pharmajournalist.com/ocugen-and-cansinobio-enter-strategic-partnership-for-gene-therapy-co-development-and-manufacturing/ 2019-10-04T09:23:45+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Ocugen_Logo.jpg http://www.pharmajournalist.com/chimerix-announces-exclusive-global-license-agreement-with-symbio-pharmaceuticals-for-brincidofovir/ 2019-10-04T09:25:43+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Chimerix-Logo.jpg http://www.pharmajournalist.com/cellular-biomedicine-group-announces-new-facility-to-expand-research-and-development-and-to-support-clinical-development/ 2019-10-04T09:28:28+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/CBMG-Logo.jpg http://www.pharmajournalist.com/xylyx-bio-announces-development-of-disease-specific-cell-culture-products-to-accelerate-anti-fibrotic-drug-discovery-and-screening/ 2019-10-04T09:32:03+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Xylyx-Logo.jpg http://www.pharmajournalist.com/prometheus-biosciences-enters-into-multi-target-strategic-collaboration-with-takeda-to-develop-targeted-therapies-for-inflammatory-bowel-disease/ 2019-10-04T09:42:30+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Prometheus-Biosciences-Logo.jpg http://www.pharmajournalist.com/focus-day-announced-for-smis-11th-annual-rna-therapeutics-conference-2020/ 2019-10-04T09:42:56+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/RNA-Therapeutics-2020.jpg http://www.pharmajournalist.com/goldfinch-bio-announces-licensing-agreement-with-takeda-for-cb1-monoclonal-antibody-for-the-treatment-of-rare-and-metabolic-kidney-diseases/ 2019-10-04T10:03:37+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Goldfinch-Bio-Logo.png http://www.pharmajournalist.com/cellectis-and-lonza-enter-cgmp-manufacturing-service-agreement-for-cellectis-allogeneic-ucart-product-candidates/ 2019-10-04T10:05:18+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/Cellectis-Logo.png http://www.pharmajournalist.com/elligo-receives-fda-grant-to-study-access-of-real-world-data-from-electronic-health-records/ 2019-10-04T10:08:06+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Elligo_Logo.jpg http://www.pharmajournalist.com/astellas-commits-nearly-13-million-to-fund-boston-area-start-up-innovation-in-cell-and-gene-therapy/ 2019-10-04T10:10:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astellas.jpg http://www.pharmajournalist.com/thermo-fisher-scientific-enhances-leading-pharma-services-offering-by-expanding-api-manufacturing-capabilities/ 2019-10-04T10:14:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/thermo-fisher-scientific.jpg http://www.pharmajournalist.com/four-interactive-sessions-to-take-place-at-the-2019-respiratory-drug-delivery-conference/ 2019-10-08T06:17:17+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/300x250.jpg http://www.pharmajournalist.com/exclusive-interview-with-optceutics-ltd-speaker-released-for-ophthalmic-drugs-conference-2019/ 2019-10-08T06:34:17+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Ophthalmic-Drugs.jpg http://www.pharmajournalist.com/digital-therapeutics-alliance-speaker-interview-released-for-disruptive-technologies-in-pharma-2020/ 2019-10-08T16:03:48+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Disruptive-Technologies-in-Pharma_Pharma-Journalist.jpg http://www.pharmajournalist.com/pharmaceutical-synthesizers-and-fragrance-pioneers-to-present-at-the-european-protein-engineering-congress-frankfurt-12th-13th-2019/ 2019-10-11T10:53:27+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Protein-Eng.png http://www.pharmajournalist.com/alexion-and-stealth-announce-agreement-for-option-to-co-develop-and-commercialize-late-stage-therapy-for-mitochondrial-diseases/ 2019-10-11T10:56:29+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Alexion-Pharma-Logo.png http://www.pharmajournalist.com/bluebird-bio-and-novo-nordisk-enter-into-research-agreement-to-develop-in-vivo-genome-editing-candidates-for-haemophilia-and-other-severe-genetic-diseases/ 2019-10-11T11:06:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/novo-nordisk-logo.jpg http://www.pharmajournalist.com/panel-discussion-set-for-pre-filled-syringes-and-injectable-drug-devices-conference/ 2019-10-11T11:06:54+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Pre-Filled-Syringes_Pharma-Journalist.jpg http://www.pharmajournalist.com/gsk-and-lyell-immunopharma-join-forces-to-develop-the-next-generation-of-cancer-cell-therapies/ 2019-10-11T11:10:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/gsk.jpg http://www.pharmajournalist.com/novartis-receives-fda-approval-for-beovu-offering-wet-amd-patients-vision-gains-and-greater-fluid-reductions-vs-aflibercept/ 2019-10-11T11:16:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/akcea-and-pfizer-announce-licensing-agreement-for-investigative-antisense-therapy-akcea-angptl3-lrx/ 2019-10-11T11:19:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/gilead-and-galapagos-announce-efficacy-and-safety-results-of-filgotinib-through-52-weeks-in-finch-1-and-finch-3-studies-in-rheumatoid-arthritis/ 2019-10-11T11:23:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/ionis-factor-xi-anti-thrombotic-medicine-advances-with-bayer-following-positive-clinical-results/ 2019-10-11T11:25:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/ionis-pharma1.jpg http://www.pharmajournalist.com/viela-bio-mitsubishi-tanabe-sign-licensing-deal-for-inebilizumab/ 2019-10-11T11:29:11+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/viela-bio-logo.jpg http://www.pharmajournalist.com/dermira-to-present-data-from-phase-2b-study-of-lebrikizumab-in-patients-with-atopic-dermatitis-at-fall-clinical-dermatology-conference/ 2019-10-11T11:32:52+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Dermira-Logo.png http://www.pharmajournalist.com/ideaya-announces-first-patient-dosing-of-ide196-for-solid-tumors-outside-of-uveal-melanoma/ 2019-10-11T11:36:24+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/IDEAYA-Biosciences-Logo.jpg http://www.pharmajournalist.com/ucb-agrees-to-acquire-ra-pharmaceuticals/ 2019-10-11T11:40:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/ucb-pharma.jpg http://www.pharmajournalist.com/hoth-therapeutics-successfully-completes-phase-i-of-in-life-dose-escalation-study-for-treating-eczema/ 2019-10-11T11:43:43+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Hoth-Therapeutics-Logo.png http://www.pharmajournalist.com/pfenex-receives-fda-approval-for-pf708-to-treat-osteoporosis/ 2019-10-11T11:49:10+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Pfenex-Logo.jpg http://www.pharmajournalist.com/advaxis-and-ucla-enter-collaboration-for-glioblastoma-immunotherapy-discovery-research/ 2019-10-11T12:06:40+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Advaxis-Logo.jpeg http://www.pharmajournalist.com/neumentum-enters-into-global-licensing-agreement-for-a-novel-class-of-investigational-pain-treatments/ 2019-10-11T12:09:39+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Neumentum-Logo.png http://www.pharmajournalist.com/correcting-and-replacing-virtrial-awarded-fda-approved-decentralized-clinical-trial-with-hope-biosciences/ 2019-10-11T12:13:34+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Virtrial-logo.png http://www.pharmajournalist.com/avacta-enters-collaboration-with-adc-therapeutics/ 2019-10-11T12:19:41+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Avacta-Logo.jpg http://www.pharmajournalist.com/adaptimmune-and-cryoport-announce-agreement-to-ensure-safe-and-fully-monitored-transport-of-adaptimmunes-cell-therapies/ 2019-10-11T12:21:40+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Adaptimmune-Therapeutics-logo.png http://www.pharmajournalist.com/cure-pharmaceutical-debuts-cureform-drug-delivery-line-adding-chewables-and-emulsions/ 2019-10-11T12:25:04+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Cure-Pharmaceuticals-Logo.png http://www.pharmajournalist.com/alcami-launches-new-rapid-sterility-testing-services/ 2019-10-11T12:26:56+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/HSA-Inspection_Almac-Group.jpg http://www.pharmajournalist.com/clinigen-launches-managed-access-program-for-progenics-pharmaceuticals-for-azedra-outside-the-us/ 2019-10-11T12:32:19+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Clinigen-Group-Logo.jpg http://www.pharmajournalist.com/smis-3d-cell-culture-conference-2020-speakers-announced/ 2019-10-15T11:59:27+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/P-310-3D-Cell-Culture-2020-banner-300x250.jpg http://www.pharmajournalist.com/adaptate-biotherapeutics-formed-to-develop-antibody-based-therapies-that-modulate-gamma-delta-t-cells/ 2019-10-18T09:02:37+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Adaptate-Biotherapeutics-Logo.jpg http://www.pharmajournalist.com/trastuzumab-deruxtecan-granted-fda-priority-review-for-treatment-of-patients-with-her2-positive-metastatic-breast-cancer/ 2019-10-18T09:21:28+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/takeda-agrees-to-divest-select-otc-and-non-core-assets-to-acino-for-over-200-million-usd/ 2019-10-18T09:41:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/sanofi-opens-digital-manufacturing-facility-in-the-us/ 2019-10-18T09:47:15+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/fda-approves-xarelto-rivaroxaban-to-help-prevent-blood-clots-in-acutely-ill-medical-patients/ 2019-10-18T09:51:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/alexion-to-acquire-achillion/ 2019-10-18T09:54:58+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Alexion-Pharma-Logo.png http://www.pharmajournalist.com/horizon-therapeutics-plc-initiates-protect-trial-evaluating-krystexxa-pegloticase-injection/ 2019-10-18T09:56:56+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/Horizon-Therapeutics-Logo.jpg http://www.pharmajournalist.com/tripharm-services-announces-creation-of-pharmaceutical-manufacturing-center/ 2019-10-18T10:02:08+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/TriPharm_Employee.jpg http://www.pharmajournalist.com/wp-content/uploads/2019/10/TriPharm_Employee.jpg http://www.pharmajournalist.com/crispr-and-ksq-therapeutics-announce-license-agreement-to-advance-companies-respective-cell-therapy-programs-in-oncology/ 2019-10-18T10:06:20+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/KSQ-Logo.jpg http://www.pharmajournalist.com/trialbee-and-trinetx-partner-to-accelerate-patient-centric-clinical-trials/ 2019-10-18T10:12:49+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/TriNetX-Logo.png http://www.pharmajournalist.com/sun-pharma-launches-drizalma-sprinkle-in-the-u-s/ 2019-10-18T10:16:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/SunPharma.jpg http://www.pharmajournalist.com/new-handheld-x-ray-fluorescence-analyzer-for-pharmaceutical-manufacturers-identifies-ionic-salt-raw-material-in-seconds/ 2019-10-18T10:18:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/thermo-fisher-scientific.jpg http://www.pharmajournalist.com/forbius-completes-enrollment-into-phase-1a-solid-tumor-trial-of-avid200-first-in-class-tgf-beta-1-closes-series-c-financing/ 2019-10-18T10:21:05+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Forbius-Logo.jpg http://www.pharmajournalist.com/teijin-and-neurosigma-enter-into-exclusive-license-agreement/ 2019-10-18T10:26:47+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/NeuroSigma-Logo.jpg http://www.pharmajournalist.com/pharmacyte-biotech-successfully-completes-manufacturing-of-clinical-trial-product/ 2019-10-18T10:31:26+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/PharmaCyte-Biotech-logo.png http://www.pharmajournalist.com/hitgen-enters-into-dna-encoded-library-based-drug-discovery-research-collaboration-with-galapagos-nv/ 2019-10-18T10:39:16+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Hitgen-Logo.jpg http://www.pharmajournalist.com/thermo-fisher-scientific-launches-new-external-molecular-control-panel-for-the-analytical-evaluation-of-bcr-abl-test-methods/ 2019-10-18T10:42:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/thermo-fisher-scientific.jpg http://www.pharmajournalist.com/mesoblast-and-lonza-enter-into-agreement-for-commercial-manufacture-of-mesoblasts-potential-first-united-states-allogeneic-therapy/ 2019-10-18T10:44:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/Lonza.jpg http://www.pharmajournalist.com/combigene-signs-agreement-with-cobra-biologics-for-production-of-candidate-drug-cg01/ 2019-10-18T10:47:36+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Cobra-Biologics-image.jpg http://www.pharmajournalist.com/ppf-and-sotio-invest-6-5-million-in-maverix-oncology-and-its-lead-program-mvx-5005/ 2019-10-18T10:50:53+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Sotio-Logo.jpg http://www.pharmajournalist.com/merck-receives-eu-chmp-positive-opinion-for-investigational-v920-ebola-zaire-vaccine-for-protection-against-ebola-virus-disease/ 2019-10-18T10:53:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/arsenalbio-launches-with-85-million-series-a-financing-to-advance-new-paradigm-to-discover-and-develop-immune-cell-therapies/ 2019-10-18T11:06:17+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/ArsenalBio-Logo.png http://www.pharmajournalist.com/co-chairs-invitation-to-smis-9th-annual-pharmaceutical-microbiology-conference/ 2019-10-18T11:19:15+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/Pharma-Micro-UK-300x250.jpg http://www.pharmajournalist.com/viiv-healthcare-submits-supplemental-new-drug-application-to-us-fda-for-use-of-dovato-in-virologically-suppressed-adults-with-hiv-1/ 2019-10-18T11:19:52+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/VIIV-Healthcare-Logo.jpg http://www.pharmajournalist.com/continuous-processing-is-the-game-changer-to-pharma-and-biotechs-in-2020-what-you-can-learn-at-4th-ccp-summit/ 2019-10-21T08:39:37+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/CCP-2020.jpg http://www.pharmajournalist.com/interactive-workshops-announced-for-smis-14th-annual-parallel-trade-conference-2020/ 2019-10-21T12:24:40+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Parallel-Trade-2020.jpg http://www.pharmajournalist.com/exclusive-interview-with-cedric-gysel-johnson-and-johnsons-cedric-gysel-for-pre-filled-syringe-and-injectable-drug-devices-2020/ 2019-10-23T10:29:12+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Pre-Filled-Syringes_Pharma-Journalist.jpg http://www.pharmajournalist.com/exclusive-speaker-interview-with-ondigital-health-consulting-released-for-disruptive-technologies-in-pharma-2020/ 2019-10-24T16:44:44+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Disruptive-Technologies-in-Pharma_Pharma-Journalist.jpg http://www.pharmajournalist.com/novartis-receives-approval-for-cosentyx-label-update-in-europe-to-include-dosing-flexibility-in-ankylosing-spondylitis/ 2019-10-25T08:46:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/janssen-seeks-to-expand-use-of-tremfya-guselkumab-in-the-treatment-of-adults-with-active-psoriatic-arthritis/ 2019-10-25T08:49:02+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Janssen-Pharma-Logo.jpg http://www.pharmajournalist.com/biogen-plans-regulatory-filing-for-aducanumab-in-alzheimers-disease-based-on-new-analysis-of-larger-dataset-from-phase-3-studies/ 2019-10-25T08:52:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Biogen-logo.jpg http://www.pharmajournalist.com/biogen-and-samsung-bioepis-to-present-data-for-infliximab-and-adalimumab-biosimilars-at-united-european-gastroenterology-week/ 2019-10-25T08:54:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Biogen-logo.jpg http://www.pharmajournalist.com/takeda-acquires-license-for-first-in-class-celiac-disease-therapy-from-cour-pharma-following-positive-phase-2a-proof-of-concept-study/ 2019-10-25T08:56:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/zealand-pharma-expands-its-peptide-platform-with-acquisition-of-encycle-therapeutics/ 2019-10-25T08:58:05+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/zealand-logo.jpg http://www.pharmajournalist.com/janssen-announces-fda-approval-of-stelara-ustekinumab-for-the-treatment-of-adults-with-moderately-to-severely-active-ulcerative-colitis/ 2019-10-25T09:00:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/Janssen.jpg http://www.pharmajournalist.com/vertex-announces-agreement-with-nhs-england-for-access-to-all-licensed-cystic-fibrosis-medicines/ 2019-10-25T09:03:57+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Vertex.jpg http://www.pharmajournalist.com/fda-approves-botox-for-pediatric-patients-with-lower-limb-spasticity/ 2019-10-25T09:04:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/verseau-launches-with-50-million-to-develop-first-in-class-macrophage-targeted-immunotherapies-and-appoints-george-golumbeski-as-chairman-of-the-board/ 2019-10-25T09:14:47+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/verseau-logo.png http://www.pharmajournalist.com/farxiga-approved-in-the-us-to-reduce-the-risk-of-hospitalisation-for-heart-failure-in-patients-with-type-2-diabetes/ 2019-10-25T09:18:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/gsk-agrees-to-divest-rabies-and-tick-borne-encephalitis-vaccines-to-bavarian-nordic/ 2019-10-25T09:19:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/moderna-receives-fda-fast-track-designation-for-propionic-acidemia-program-mrna-3927/ 2019-10-25T09:25:22+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Moderna-Logo.png http://www.pharmajournalist.com/knight-therapeutics-to-acquire-grupo-biotoscana-establishing-a-latin-american-growth-platform/ 2019-10-25T09:30:54+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Knight-Therapeutics.png http://www.pharmajournalist.com/alexion-receives-fda-approval-for-ultomiris-ravulizumab-cwvz-for-atypical-hemolytic-uremic-syndrome-ahus/ 2019-10-25T09:33:41+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Alexion-Pharma-Logo.png http://www.pharmajournalist.com/odonate-therapeutics-announces-completion-of-enrollment-in-contessa-metastatic-breast-cancer-trial/ 2019-10-25T09:37:43+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/odonate-therapeutics-logo.jpg http://www.pharmajournalist.com/aztherapies-strengthens-neuroinflammation-targeted-pipeline-through-acquisition-of-smith-therapeutics/ 2019-10-25T09:41:26+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/AZTherapies-Logo.jpg http://www.pharmajournalist.com/avrobio-receives-orphan-drug-designation-from-the-fda-for-avr%e2%80%91rd%e2%80%9102-for-the-treatment-of-gaucher-disease/ 2019-10-25T09:44:13+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/AVROBIO-Logo.png http://www.pharmajournalist.com/pliant-therapeutics-announces-strategic-collaboration-to-develop-novel-therapies-for-nash-and-fibrotic-diseases/ 2019-10-25T09:49:31+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/pliant_entryway.png http://www.pharmajournalist.com/foamix-enters-into-manufacturing-and-supply-agreement-for-amzeeq-and-fmx103/ 2019-10-25T09:53:44+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Foamix_Logo.jpg http://www.pharmajournalist.com/moberg-pharma-and-dongkoo-sign-agreement-for-mob-015-in-the-republic-of-korea/ 2019-10-25T09:59:59+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Moberg-Pharma-Logo.jpg http://www.pharmajournalist.com/bryn-pharma-partners-with-aptar-pharma-for-nasal-epinephrine-treatment/ 2019-10-25T10:02:54+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Nasal-Epinephrine-Treatment.jpg https://pharmajournalist.com/wp-content/uploads/2019/10/Nasal-Epinephrine-Treatment.jpg http://www.pharmajournalist.com/pds-biotechnology-completes-manufacturing-of-clinical-batches-of-pds0101/ 2019-10-25T10:06:00+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/PDS-Biotechnology-Logo.png http://www.pharmajournalist.com/targeting-rna/ 2019-10-28T11:15:12+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/Targeting-RNA-Congress.gif http://www.pharmajournalist.com/empowering-strategies-for-emerging-platform-companies-in-the-rna-field/ 2019-10-28T11:20:29+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/RNA-TDD-Pharma-Journalist-Banner.png http://www.pharmajournalist.com/under-the-spotlight-genentech-the-rna-medicines-company-workshops-on-drug-discovery-approaches-to-rna-empowering-rna-drug-target-validation/ 2019-10-28T11:24:28+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/RNA-TDD-Pharma-Journalist-Banner.png http://www.pharmajournalist.com/exclusive-interview-from-conference-speaker-richard-marsden-released-ahead-of-smis-respiratory-drug-delivery-conference/ 2019-10-29T10:54:56+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/300x250.jpg http://www.pharmajournalist.com/insight-into-the-latest-developments-in-oligonucleotide-delivery-systems/ 2019-10-29T12:06:28+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/RNA-Therapeutics-2020.jpg http://www.pharmajournalist.com/exclusive-interview-with-conference-speaker-che-connon-released-ahead-of-smis-ophthalmic-drugs-conference/ 2019-10-29T12:43:58+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Ophthalmic-Drugs.jpg http://www.pharmajournalist.com/registration-opens-for-smis-ai-in-drug-discovery-conference-2020/ 2019-10-29T12:58:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/smi-logo.png http://www.pharmajournalist.com/predict-tumour-models-london-speaker-interview-stemonix/ 2019-10-30T11:12:26+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Fabian-Zanella-Director-of-RD-Stemonix.jpg http://www.pharmajournalist.com/tmunity-raises-75-million-in-series-b-financing-to-advance-next-generation-t-cell-therapies/ 2019-11-01T10:04:54+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/Tmunity-Logo.png http://www.pharmajournalist.com/amgen-enters-into-strategic-collaboration-with-beigene-to-expand-oncology-presence-in-china/ 2019-11-01T10:07:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg http://www.pharmajournalist.com/roches-marketing-applications-for-satralizumab-in-neuromyelitis-optica-spectrum-disorder-accepted-for-review-by-ema-and-fda/ 2019-11-01T10:09:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/dicerna-enters-alliance-to-develop-hepatitis-b-drugs/ 2019-11-01T10:23:45+00:00 https://pharmajournalist.com/wp-content/uploads/2019/07/Dicerna-Logo.png http://www.pharmajournalist.com/biogen-and-alkermes-announce-fda-approval-of-vumerity-diroximel-fumarate-for-multiple-sclerosis/ 2019-11-01T10:26:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Biogen-logo.jpg http://www.pharmajournalist.com/pandion-and-astellas-announce-collaboration-to-deliver-pancreas-targeted-immunomodulators/ 2019-11-01T10:29:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astellas.jpg http://www.pharmajournalist.com/novartis-announces-avxs-101-intrathecal-study-update/ 2019-11-01T10:33:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/enesi-pharma-gets-funding-to-develop-measles-and-rubella-vaccines/ 2019-11-01T10:42:41+00:00 https://pharmajournalist.com/wp-content/uploads/2019/11/Enesi-Pharma-Logo.jpg http://www.pharmajournalist.com/astrazeneca-divests-rights-to-seroquel-and-seroquel-xr-in-europe-and-russia/ 2019-11-01T10:50:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/dupixent-dupilumab-now-approved-in-european-union-for-severe-chronic-rhinosinusitis-with-nasal-polyposis/ 2019-11-01T10:53:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/sanofi.jpg http://www.pharmajournalist.com/gilead-and-glympse-bio-announce-strategic-collaboration-for-use-of-biomarker-technology-in-nash-clinical-development/ 2019-11-01T10:55:28+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/carsgen-announces-investigational-car-t-therapy-ct053-granted-rmat-designation-by-the-fda-for-r-r-multiple-myeloma/ 2019-11-01T10:59:50+00:00 https://pharmajournalist.com/wp-content/uploads/2019/11/Carsgen-Therapeutics-Logo.jpg http://www.pharmajournalist.com/ziopharm-oncology-and-md-anderson-cancer-center-announce-new-rd-agreement-to-expand-tcr-t-program/ 2019-11-01T11:04:15+00:00 https://pharmajournalist.com/wp-content/uploads/2019/11/Ziopharm-Oncology-Logo.png http://www.pharmajournalist.com/gsk-starts-a-phase-iii-clinical-programme-for-a-potential-first-in-class-antibiotic-gepotidacin/ 2019-11-01T11:06:28+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/gsk.jpg http://www.pharmajournalist.com/alvogen-announces-divestment-of-its-central-and-eastern-european-business-to-zentiva-group/ 2019-11-01T11:13:50+00:00 https://pharmajournalist.com/wp-content/uploads/2019/11/alvogen-logo.png http://www.pharmajournalist.com/daiichi-sankyo-initiates-clinical-trial-of-ds-7300-in-collaboration-with-sarah-cannon-research-institute/ 2019-11-01T11:16:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/Daiichi-Pharma.jpg http://www.pharmajournalist.com/acadia-pharmaceuticals-initiates-phase-3-pivotal-study-of-trofinetide-in-rett-syndrome/ 2019-11-01T11:19:23+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/ACADIA-Pharma-Logo.jpg http://www.pharmajournalist.com/themis-bioscience-and-cepi-announce-initiation-of-phase-1-clinical-trial-with-lassa-fever-vaccine/ 2019-11-01T11:23:44+00:00 https://pharmajournalist.com/wp-content/uploads/2019/11/Themis_logo.jpg http://www.pharmajournalist.com/boehringer-ingelheim-advances-first-pan-kras-inhibitor-bi-1701963-into-clinical-testing/ 2019-11-01T11:25:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/ec-approves-pfizers-bavencio-plus-axitinib-to-treat-advanced-rcc/ 2019-11-01T11:28:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/nuchem-therapeutics-completed-the-acquisition-of-amplia-pharmatek/ 2019-11-01T11:31:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/cyclo-therapeutics-signs-agreement-with-worldwide-clinical-trials-to-conduct-alzheimers-disease-clinical-trial/ 2019-11-01T11:33:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/pascal-and-y-biologics-announce-research-collaboration-for-development-of-a-bispecific-antibody-for-leukemia/ 2019-11-01T11:37:17+00:00 https://pharmajournalist.com/wp-content/uploads/2019/11/Pascal-Biosciences-Logo.png http://www.pharmajournalist.com/histoindex-announces-global-partnerships-to-expand-ai-based-digital-pathology-platform/ 2019-11-01T11:40:29+00:00 https://pharmajournalist.com/wp-content/uploads/2019/11/HistoIndex-Logo.png http://www.pharmajournalist.com/exclusive-interview-from-conference-speaker-torsten-kneuss-released-ahead-of-smis-pre-filled-syringes-and-injectable-drug-devices-conference/ 2019-11-04T09:26:11+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Pre-Filled-Syringes_Pharma-Journalist.jpg http://www.pharmajournalist.com/exclusive-interview-from-conference-speaker-john-lisman-released-ahead-of-parallel-trade-2020/ 2019-11-04T09:35:32+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Parallel-Trade-2020.jpg http://www.pharmajournalist.com/smis-22nd-annual-superbugs-superdrugs-conference-2020-speakers-announced-brochure-released/ 2019-12-15T08:56:37+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/Superbugs-Superdrugs-2020.jpg http://www.pharmajournalist.com/boehringer-ingelheim-to-present-data-at-ras-summit-europe/ 2019-12-15T08:58:13+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/RAS-EU-Pharma-Journalist-Banner.png http://www.pharmajournalist.com/rna-therapeutics-2020-to-highlight-downregulating-therapeutic-technologies/ 2019-12-15T08:59:44+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/RNA-Therapeutics-2020.jpg http://www.pharmajournalist.com/exclusive-interview-from-astrazeneca-speaker-released-for-smis-pre-filled-syringes-2020-conference/ 2019-12-15T09:01:55+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Pre-Filled-Syringes_Pharma-Journalist.jpg http://www.pharmajournalist.com/key-reasons-to-attend-smis-3d-cell-culture-conference-2020/ 2019-12-15T09:03:00+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/P-310-3D-Cell-Culture-2020-banner-300x250.jpg http://www.pharmajournalist.com/speaker-spotlight-developing-long-acting-injectables/ 2019-12-15T09:07:08+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/Joel-Richard-MedinCell.jpg http://www.pharmajournalist.com/wp-content/uploads/2019/12/Joel-Richard-MedinCell.jpg http://www.pharmajournalist.com/exclusive-speaker-interview-released-for-smis-ai-in-drug-discovery-conference-2020/ 2019-12-15T09:08:44+00:00 https://pharmajournalist.com/wp-content/uploads/2019/11/AI-Drug-Discovery.jpg http://www.pharmajournalist.com/panel-discussion-on-underlying-principles-of-the-eu-internal-market-and-competition-policies-to-be-held-at-parallel-trade-2020/ 2019-12-15T09:10:14+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Parallel-Trade-2020.jpg http://www.pharmajournalist.com/6-ways-to-finally-drug-ras-oncogenes/ 2019-12-15T09:11:12+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/RAS-EU-Pharma-Journalist-Banner.png http://www.pharmajournalist.com/sanofi-to-present-at-disruptive-technologies-in-pharma-2020/ 2019-12-15T09:12:43+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/Disruptive-Technologies-in-Pharma_Pharma-Journalist.jpg http://www.pharmajournalist.com/rna-therapeutics-2020-to-highlight-developments-in-delivery-mechanisms/ 2019-12-15T09:14:41+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/RNA-Therapeutics-2020.jpg http://www.pharmajournalist.com/top-decision-makers-to-present-at-smis-9th-annual-pharmaceutical-microbiology-conference-2020/ 2019-12-15T09:17:20+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/Pharma-Micro-UK-300x250.jpg http://www.pharmajournalist.com/registration-is-now-open-for-pre-filled-syringes-east-coast/ 2019-12-15T09:19:13+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/Pre-filled-Syringes-East-Coast_Pharma-Journalist.jpg http://www.pharmajournalist.com/workshop-details-announced-for-smis-ai-in-drug-discovery-conference-2020/ 2019-12-15T09:21:16+00:00 https://pharmajournalist.com/wp-content/uploads/2019/11/AI-Drug-Discovery.jpg http://www.pharmajournalist.com/speaker-spotlight-inhaled-therapy-formulations-for-alternative-therapeutic-areas/ 2019-12-15T09:24:25+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/pavan-muttil-289x300.jpg https://pharmajournalist.com/wp-content/uploads/2019/12/pavan-muttil-289x300.jpg http://www.pharmajournalist.com/registration-opens-for-smis-3rd-annual-pharmaceutical-microbiology-east-coast-conference/ 2019-12-15T09:28:46+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/P-316-Pharma-Microbiology-EC-300-x-250.jpg http://www.pharmajournalist.com/panel-discussion-on-deep-dive-shortages-the-impact-on-patient-safety-to-be-held-at-parallel-trade-2020/ 2019-12-15T09:35:58+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Parallel-Trade-2020.jpg http://www.pharmajournalist.com/interview-released-stefan-przyborski-chairman-for-smis-3d-cell-culture-conference-2020/ 2019-12-15T09:37:19+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/P-310-3D-Cell-Culture-2020-banner-300x250.jpg http://www.pharmajournalist.com/internet-of-medical-things-the-latest-developments/ 2019-12-15T09:38:28+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/Disruptive-Technologies-in-Pharma_Pharma-Journalist.jpg http://www.pharmajournalist.com/pre-filled-syringes-east-coast-2020-to-discuss-key-topics-driving-the-industry/ 2019-12-15T09:39:42+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/Pre-filled-Syringes-East-Coast_Pharma-Journalist.jpg http://www.pharmajournalist.com/pharma-microbiology-uk-conference-to-discuss-environmental-monitoring/ 2019-12-15T09:41:58+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/Pharma-Micro-UK-300x250.jpg http://www.pharmajournalist.com/exclusive-interview-from-christiane-niederlaender-director-at-ambr-consulting-ltd-released-ahead-of-smis-rna-therapeutics-conference/ 2019-12-15T09:43:41+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/RNA-Therapeutics-2020.jpg http://www.pharmajournalist.com/dr-samareh-lajaunias-director-at-combioxin-speaking-at-smis-22nd-annual-superbugs-superdrugs-conference/ 2019-12-15T09:46:49+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/Superbugs-Superdrugs-2020.jpg http://www.pharmajournalist.com/exclusive-interview-from-hk-packaging-consulting-speaker-released-for-smis-pre-filled-syringes-2020-conference/ 2019-12-15T09:47:57+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Pre-Filled-Syringes_Pharma-Journalist.jpg http://www.pharmajournalist.com/xbiotech-announces-agreement-to-sell-true-human-antibody-bermekimab-targeting-il-1a-to-janssen/ 2019-12-15T13:54:37+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/Xbiotech-1.jpg http://www.pharmajournalist.com/invite-from-lynne-ensor-chair-for-pharma-microbiology-east-coast-conference-april-2020-boston/ 2019-12-15T13:55:50+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/P-316-Pharma-Microbiology-EC-300-x-250.jpg http://www.pharmajournalist.com/3m-to-divest-substantially-all-of-its-drug-delivery-business-to-altaris-capital-partners/ 2019-12-15T13:57:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/drug.jpg http://www.pharmajournalist.com/amneal-receives-abbreviated-new-drug-application-approval-for-eluryng-the-first-generic-nuvaring/ 2019-12-15T13:58:49+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/Amneal-Pharma.jpg http://www.pharmajournalist.com/iktos-and-almirall-announce-research-collaboration-in-ai-for-new-drug-design/ 2019-12-15T14:00:49+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/Almirall.jpg http://www.pharmajournalist.com/sarepta-announces-fda-approval-of-vyondys-53-for-the-treatment-dmd/ 2019-12-15T14:02:22+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/Sarepta-Therapeutics.jpg http://www.pharmajournalist.com/equillium-biocon-expand-exclusive-licensing-agreement-for-itolizumab-to-include-australia-and-new-zealand/ 2019-12-15T14:03:56+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/Equillium_Logo-1.png http://www.pharmajournalist.com/neoimmunetech-announces-clinical-collaboration-to-evaluate-hyleukin-7-nt-i7/ 2019-12-15T14:05:21+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/NeoImmuneTech-Logo-1.jpg http://www.pharmajournalist.com/forendo-pharma-signs-important-license-and-collaboration-deal-with-leading-pharma-company/ 2019-12-15T14:06:39+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/Forendo-Pharma-Logo-1.png http://www.pharmajournalist.com/leo-pharmas-tralokinumab-meets-key-endpoints-in-phase-3-atopic-dermatitis-trials/ 2019-12-15T14:08:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/leo-pharma.jpg http://www.pharmajournalist.com/bloom-science-collaborates-with-cedars-sinai-medical-center-to-expand-microbiome-research-and-discovery-into-brain-cancer/ 2019-12-15T14:09:50+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/Bloom-Science-Logo-1.png http://www.pharmajournalist.com/retrogenix-and-resonant-therapeutics-announce-strategic-alliance-to-identify-targets-of-anti-tumor-antibodies/ 2019-12-15T14:11:16+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/RETROGENIX-Logo-1.png http://www.pharmajournalist.com/dermira-receives-fast-track-designation-from-fda-for-lebrikizumab-for-the-treatment-of-atopic-dermatitis/ 2019-12-15T14:13:03+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Dermira-Logo.png http://www.pharmajournalist.com/flagship-pioneering-unveils-cellarity-the-first-company-to-discover-medicines-targeting-cell-behavior/ 2019-12-15T14:14:09+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/Cellarity-Logo-1.jpg http://www.pharmajournalist.com/amneal-to-acquire-majority-interest-in-avkare-enhancing-access-to-growing-federal-healthcare-market/ 2019-12-15T14:16:07+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/Amneal-Pharma.jpg http://www.pharmajournalist.com/regeneron-and-sanofi-announce-intent-to-restructure-antibody-collaboration-for-kevzara-and-praluent/ 2019-12-15T14:17:25+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/regeneron.jpg http://www.pharmajournalist.com/metp-pharma-receives-us-patent-for-drug-therapy-of-demyelinating-and-neuroinflammatory-diseases-such-as-multiple-sclerosis/ 2019-12-15T14:19:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/drug-discovery.jpg http://www.pharmajournalist.com/gemini-therapeutics-and-avitide-enter-into-exclusive-license-agreement/ 2019-12-15T14:21:17+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/Gemini-Therapeutics-Logo-1.png http://www.pharmajournalist.com/incheon-city-envisions-biotech-mecca-by-developing-songdo-global-biotech-cluster/ 2019-12-15T14:23:15+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/IFEZ-1.jpg http://www.pharmajournalist.com/wp-content/uploads/2019/12/IFEZ-1.jpg http://www.pharmajournalist.com/sanofi-to-acquire-synthorx-to-bolster-its-immuno-oncology-pipeline-for-2-5-billion/ 2019-12-15T14:24:41+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/healx-joins-forces-with-boehringer-to-discover-new-treatment-approaches-for-rare-neurological-diseases/ 2019-12-15T14:27:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/merck-to-acquire-arqule-advancing-leadership-in-oncology/ 2019-12-15T14:29:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/abbvie-and-scripps-research-announce-collaboration-to-develop-a-broad-range-of-new-therapeutics/ 2019-12-15T14:30:53+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/janssen-to-acquire-investigational-bermekimab-from-xbiotech/ 2019-12-15T14:32:31+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Janssen-Pharma-Logo.jpg http://www.pharmajournalist.com/fda-approves-avsola-infliximab-axxq-a-biosimilar-to-remicade/ 2019-12-15T14:34:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg http://www.pharmajournalist.com/roche-concludes-acquisition-of-spark-therapeutics-to-strengthen-presence-in-gene-therapy/ 2019-12-20T09:58:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/gbt-and-syros-partner-to-discover-develop-and-commercialize-novel-therapies-for-sickle-cell-disease-and-beta-thalassemia/ 2019-12-20T10:02:12+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/GBT-Logo.png http://www.pharmajournalist.com/xtandi-enzalutamide-approved-by-fda-for-the-treatment-of-metastatic-castration-sensitive-prostate-cancer/ 2019-12-20T10:07:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astellas.jpg http://www.pharmajournalist.com/cytodyn-signs-definitive-agreements-with-vyera-to-commercialize-leronlimab-in-the-u-s-for-the-treatment-of-hiv/ 2019-12-20T10:09:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/Cytodyn-Logo.jpg http://www.pharmajournalist.com/triplet-therapeutics-launches-to-focus-on-huntingtons-disease-drugs/ 2019-12-20T10:12:22+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/Triplet-Therapeutics-Logo.png http://www.pharmajournalist.com/vaccitech-enters-collaboration-with-cruk-to-fund-a-phase-i-iia-clinical-trial-as-first-line-nsclc-therapy/ 2019-12-20T10:14:43+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/Vaccitech-Logo.png http://www.pharmajournalist.com/charles-river-laboratories-to-acquire-hemacare-corporation/ 2019-12-20T10:17:34+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Charles-River.jpeg http://www.pharmajournalist.com/umass-medical-school-ge-healthcare-life-sciences-to-establish-viral-vector-manufacturing-facility/ 2019-12-20T10:19:37+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/UMASS.gif http://www.pharmajournalist.com/wp-content/uploads/2019/12/UMASS.gif http://www.pharmajournalist.com/amarin-receives-fda-approval-of-vascepa-icosapent-ethyl-to-reduce-cardiovascular-risk/ 2019-12-20T10:23:59+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/Amarin-Corporation-Logo.jpg http://www.pharmajournalist.com/pfizer-receives-positive-chmp-opinion-for-vyndaqel-for-use-in-patients-with-transthyretin-amyloid-cardiomyopathy-a-rare-and-fatal-disease/ 2019-12-20T10:27:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/viiv-healthcare-seeks-approval-for-child-friendly-hiv-treatment/ 2019-12-20T10:30:36+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/VIIV-Healthcare-Logo.jpg http://www.pharmajournalist.com/genmab-and-curevac-enter-strategic-partnership-to-develop-mrna-based-antibody-therapeutics/ 2019-12-20T10:31:54+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Genmab-Logo.jpg http://www.pharmajournalist.com/pharmamar-and-jazz-pharmaceuticals-sign-exclusive-license-agreement-for-lurbinectedin-in-the-u-s/ 2019-12-20T10:35:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/jazz-pharmaceuticals.jpg http://www.pharmajournalist.com/bioarctic-announces-research-collaboration-with-eisai-regarding-ban2401/ 2019-12-20T10:38:00+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/Bioarctic-Logo.jpg http://www.pharmajournalist.com/shandong-fontacea-announces-license-agreement-with-janssen/ 2019-12-20T10:48:45+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/fontacea_logo.jpg http://www.pharmajournalist.com/organovo-and-tarveda-therapeutics-announce-definitive-merger-agreement/ 2019-12-20T10:50:35+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Organovo-logo.jpg http://www.pharmajournalist.com/achillion-shareholders-approve-agreement-to-be-acquired-by-alexion/ 2019-12-20T10:52:37+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/Achillion-Logo.png http://www.pharmajournalist.com/fda-committee-recommends-approval-of-keytruda-in-high-risk-nmibc/ 2019-12-20T10:55:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/amylyx-pharmaceuticals-announces-amx0035-demonstrated-statistically-significant-treatment-benefit-for-people-with-als-in-the-centaur-trial/ 2019-12-20T10:57:23+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/Amylyx-Logo.jpg http://www.pharmajournalist.com/dicerna-receives-orphan-drug-designation-from-ec-for-dcr-a1at-for-treatment-of-congenital-a1at-deficiency/ 2019-12-20T10:59:28+00:00 https://pharmajournalist.com/wp-content/uploads/2019/07/Dicerna-Logo.png http://www.pharmajournalist.com/dicerna-announces-closing-of-worldwide-collaboration-and-licensing-agreement-with-roche/ 2019-12-20T11:01:31+00:00 https://pharmajournalist.com/wp-content/uploads/2019/07/Dicerna-Logo.png http://www.pharmajournalist.com/astrazeneca-divests-rights-to-arimidex-and-casodex-in-europe-and-certain-additional-countries/ 2019-12-20T11:02:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/lynparza-recommended-by-fda-advisory-committee-for-1st-line-maintenance-treatment-of-germline-brca-mutated-metastatic-pancreatic-cancer/ 2019-12-20T11:04:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/boehringer-and-lilly-provide-update-on-jardiance-phase-iii-exercise-ability-studies-in-chronic-heart-failure/ 2019-12-20T11:07:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/abcam-and-somaserve-announce-comprehensive-partnership-to-realise-the-potential-of-polynaut-bionic-nanoparticles-for-delivery-to-live-cells/ 2019-12-20T11:09:26+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Abcam-Logo.jpg http://www.pharmajournalist.com/bc-platforms-closes-15-million-series-c-financing-and-signs-partnership-with-iqvia-to-extend-data-analytics-in-genomics/ 2019-12-20T11:11:53+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/BC-Platforms-Logo.png http://www.pharmajournalist.com/just-two-weeks-to-go-until-smis-flagship-pharmaceutical-microbiology-uk-conference/ 2020-01-06T08:59:01+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/Pharma-Micro-UK-300x250.jpg http://www.pharmajournalist.com/co-chair-invite-letter-released-ahead-of-smis-4th-annual-3d-cell-culture-conference/ 2020-01-06T09:03:55+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/P-310-3D-Cell-Culture-2020-banner-300x250.jpg http://www.pharmajournalist.com/key-sessions-you-cannot-afford-to-miss-at-smis-12th-annual-european-pre-filled-syringes-conference-2020/ 2020-01-06T14:21:52+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Pre-Filled-Syringes_Pharma-Journalist.jpg http://www.pharmajournalist.com/exclusive-interview-with-conference-speaker-shikta-das-released-ahead-of-disruptive-technologies-in-pharma-2020/ 2020-01-07T10:50:15+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/Disruptive-Technologies-in-Pharma_Pharma-Journalist.jpg http://www.pharmajournalist.com/less-than-six-weeks-to-go-until-smis-rna-therapeutics-conference/ 2020-01-07T10:54:53+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/RNA-Therapeutics-2020.jpg http://www.pharmajournalist.com/5-questions-for-lab-leaders/ 2020-01-09T10:07:02+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/PJ-300x250-SLABS-US-2020-Banner.png http://www.pharmajournalist.com/altavant-sciences-acquires-onspira-therapeutics/ 2020-01-09T10:50:22+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/Altavant-Sciences-Logo.png http://www.pharmajournalist.com/almirall-enters-into-an-option-agreement-to-acquire-bioniz-therapeutics/ 2020-01-09T10:52:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Almirall_Plant_Reinbek.jpg http://www.pharmajournalist.com/mina-therapeutics-announces-research-collaboration-with-astrazeneca-in-metabolic-diseases/ 2020-01-09T10:55:36+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/MiNA-Therapeutics-Logo.jpg http://www.pharmajournalist.com/registration-opens-for-smis-3rd-annual-injectable-drug-delivery-in-london/ 2020-01-09T10:57:27+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/Injectable-drug-delivery.jpg http://www.pharmajournalist.com/galen-announces-completion-of-multi-million-pound-poa-pharma-acquisition/ 2020-01-09T10:57:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/bicycle-therapeutics-and-cancer-research-uk-to-collaborate-on-development-of-new-bicycle-immuno-oncology-candidate-bt7401/ 2020-01-09T10:59:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/Bicycle-Therapeutics.jpg http://www.pharmajournalist.com/fda-approves-fiasp-for-treatment-of-children-with-diabetes/ 2020-01-09T11:03:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/novo-nordisk-logo.jpg http://www.pharmajournalist.com/merck-establishes-strategic-oncology-collaboration-with-taiho-and-astex/ 2020-01-09T11:05:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/astrazeneca-secures-fda-priority-review-for-farxiga/ 2020-01-09T11:07:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/leap-therapeutics-and-beigene-announce-exclusive-option-and-license-agreement-for-dkn-01-and-leap-announces-27-million-equity-financing/ 2020-01-09T11:12:07+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/Leap-Therapeutics-Logo.jpg http://www.pharmajournalist.com/charles-river-laboratories-completes-the-acquisition-of-hemacare-corporation/ 2020-01-09T11:14:13+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Charles-River.jpeg http://www.pharmajournalist.com/abcam-announces-successful-acquisition-of-expedeons-proteomics-and-immunology-business-enhancing-its-conjugation-capability/ 2020-01-09T11:15:30+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Abcam-Logo.jpg http://www.pharmajournalist.com/pulmatrix-announces-research-collaboration-with-nocion-therapeutics-to-explore-inhaled-drug-delivery-technologies/ 2020-01-09T11:17:05+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Pulmatrix-Logo.jpg http://www.pharmajournalist.com/atai-life-sciences-partners-with-neuronasal-inc-to-develop-novel-treatment-for-mtbi/ 2020-01-09T11:19:31+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/ATAI-Life-Sciences-Logo.png http://www.pharmajournalist.com/inxmed-announces-clinical-collaboration-with-msd-to-evaluate-in10018-in-combination-with-pembrolizumab/ 2020-01-09T11:21:28+00:00 https://pharmajournalist.com/wp-content/uploads/2017/02/abzena-clinical.jpg http://www.pharmajournalist.com/curis-announces-option-and-license-agreement-with-immunext-for-the-development-and-commercialization-of-anti-vista-antibodies/ 2020-01-09T11:23:47+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/Curis-Logo.png http://www.pharmajournalist.com/galecto-and-pharmakea-merge-to-create-strong-clinical-stage-company-developing-first-in-class-therapeutics-in-fibrosis-and-cancer/ 2020-01-09T11:26:50+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/Galecto-Logo.png http://www.pharmajournalist.com/schrodinger-and-bayer-collaborate-to-co-develop-de-novo-design-technology-to-accelerate-drug-discovery/ 2020-01-09T11:29:38+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/Schrodinger-Logo.png http://www.pharmajournalist.com/catabasis-and-duchenne-announce-partnership-to-evaluate-edasalonexent-in-a-phase-2-non-ambulatory-dmd-trial/ 2020-01-09T11:33:19+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/Catabasis-Logo.jpg http://www.pharmajournalist.com/incyte-announces-validation-by-ema-of-its-maa-for-pemigatinib-in-patients-with-cholangiocarcinoma/ 2020-01-09T11:36:02+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/incyte-logo.jpg http://www.pharmajournalist.com/veristat-strengthens-its-european-presence-with-the-acquisition-of-the-clinical-trial-company/ 2020-01-09T11:38:34+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/Veristat.jpg http://www.pharmajournalist.com/mercachemsyncom-closes-acquisition-of-alcami-weert/ 2020-01-10T10:15:18+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/MercachemSyncom.png http://www.pharmajournalist.com/ppd-expanding-clinical-development-and-laboratory-capabilities-in-china/ 2020-01-10T10:16:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/PPD-office_wikipedia.jpg http://www.pharmajournalist.com/hikma-and-arecor-announce-exclusive-agreement-to-develop-and-commercialise-ready-to-use-medicine-using-arestat-technology/ 2020-01-10T10:19:27+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/hikma-logo.jpg http://www.pharmajournalist.com/almirall-and-wuxi-biologics-sign-strategic-collaboration-agreement-for-multiple-bispecific-antibodies-targeting-dermatology-diseases/ 2020-01-10T10:20:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Almirall_Plant_Reinbek.jpg http://www.pharmajournalist.com/immunic-exercises-its-option-for-the-exclusive-worldwide-license-to-imu-856-from-daiichi-sankyo/ 2020-01-10T10:23:37+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/Immunic-Therapeutics-Logo.jpg http://www.pharmajournalist.com/candel-therapeutics-acquires-next-generation-herpes-drug-development-platform-and-manufacturing-expertise/ 2020-01-10T10:25:31+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/Candel-Therapeutics-Logo.jpg http://www.pharmajournalist.com/avacta-and-daewoong-pharmaceutical-form-immunotherapy-focused-joint-venture/ 2020-01-10T10:36:58+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Avacta-Logo.jpg http://www.pharmajournalist.com/probiogen-inks-next-commercial-glymaxx-license-with-roche/ 2020-01-10T10:38:31+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/ProBioGen-Logo.png http://www.pharmajournalist.com/evotec-and-bristol-myers-squibb-expand-ipsc-collaboration/ 2020-01-10T10:39:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/evotec.png http://www.pharmajournalist.com/evotec-scynexis-to-lead-the-workshops-for-superbugs-superdrugs-2020/ 2020-01-13T08:36:10+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/P-312-Superbugs-Superdrugs-WorkshopA-banner.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/01/P-312-Superbugs-Superdrugs-WorkshopA-banner.jpg http://www.pharmajournalist.com/registration-opens-for-highly-potent-active-pharmaceutical-ingredients-2020/ 2020-01-13T11:04:53+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/HPAPI-London-Pharma-Journalist-Banner.jpg http://www.pharmajournalist.com/pre-filled-syringes-east-coast-2020-to-discuss-digital-connectivity-in-the-pfs-industry/ 2020-01-14T08:14:03+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/Pre-filled-Syringes-East-Coast_Pharma-Journalist.jpg http://www.pharmajournalist.com/exclusive-interview-with-conference-speaker-martin-slegl-released-ahead-of-parallel-trade-2020/ 2020-01-14T10:57:34+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Parallel-Trade-2020.jpg http://www.pharmajournalist.com/exclusive-interview-with-robert-young-released-ahead-of-ai-in-drug-discovery-2020/ 2020-01-14T10:59:00+00:00 https://pharmajournalist.com/wp-content/uploads/2019/11/AI-Drug-Discovery.jpg http://www.pharmajournalist.com/dermavant-enters-into-exclusive-license-agreement-with-jt-for-development-and-commercialization-of-tapinarof-in-japan/ 2020-01-17T09:27:47+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/dermavant-logo.jpg http://www.pharmajournalist.com/clovis-oncologys-rubraca-rucaparib-granted-fda-priority-review-for-advanced-prostate-cancer/ 2020-01-17T09:29:51+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/Clovis-Oncology-Logo.png http://www.pharmajournalist.com/bms-secures-fda-priority-review-for-nsclc-treatment-combination/ 2020-01-17T09:32:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/fibrocor-and-galapagos-sign-expanded-collaboration-in-fibrosis/ 2020-01-17T09:39:10+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/Fibrocor-Logo.png http://www.pharmajournalist.com/morphosys-and-incyte-sign-global-collaboration-and-license-agreement-for-tafasitamab/ 2020-01-17T09:53:31+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/MorphoSys-AG.jpg http://www.pharmajournalist.com/coherus-acquires-commercial-rights-for-avastin-biosimilar-in-the-united-states/ 2020-01-17T09:56:50+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/Coherus-Biosciences-Logo.png http://www.pharmajournalist.com/fda-grants-priority-review-for-astrazenecas-lynparza/ 2020-01-17T09:58:55+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/iovance-and-cellectis-enter-into-a-research-collaboration-and-exclusive-worldwide-license-agreement/ 2020-01-17T10:04:05+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Iovance-Biotherapeutics-Logo.jpg http://www.pharmajournalist.com/neurobo-pharmaceuticals-and-gemphire-therapeutics-complete-merger/ 2020-01-17T10:05:54+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/NeuroBo-Logo.jpg http://www.pharmajournalist.com/lilly-announces-agreement-to-acquire-dermira/ 2020-01-17T10:07:25+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/effector-enters-into-agreement-with-pfizer-to-develop-novel-first-in-class-inhibitors-of-eif4e-to-treat-multiple-cancer-types/ 2020-01-17T10:20:10+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/eFFECTOR-Therapeutics-Logo.jpg http://www.pharmajournalist.com/zymeworks-announces-agreement-with-pfizer-and-initiation-of-a-new-phase-2-trial-evaluating-zw25-in-combination-with-ibrance-palbociclib/ 2020-01-17T10:23:36+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/ZymeWorks-Logo.png http://www.pharmajournalist.com/artisan-bio-announces-global-research-and-discovery-collaboration-agreement-with-takeda-to-develop-next-generation-cell-therapy-products/ 2020-01-17T10:26:35+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/ArtisanBio-Logo.png http://www.pharmajournalist.com/numedii-announces-pharmaceutical-discovery-collaboration-for-ulcerative-colitis/ 2020-01-17T10:29:10+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/NuMedii-Logo.png http://www.pharmajournalist.com/neuroptika-announces-enrollment-of-first-patient-in-phase-2-clinical-trial-for-dry-eye-disease/ 2020-01-17T10:32:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/twist-bioscience-announces-strategic-collaboration-with-schrodinger-for-drug-discovery/ 2020-01-17T10:33:59+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/Twist-Bioscience-logo.jpg http://www.pharmajournalist.com/astellas-and-adaptimmune-enter-into-agreement-to-co-develop-and-co-commercialize-stem-cell-derived-allogeneic-car-t-and-tcr-t-cell-therapies/ 2020-01-17T10:36:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astellas.jpg http://www.pharmajournalist.com/biomotiv-and-atomwise-sign-ai-partnership-to-transform-therapeutic-development/ 2020-01-17T10:41:51+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/BioMotiv-Logo.jpg http://www.pharmajournalist.com/charles-river-and-takeda-announce-scientific-collaboration-to-identify-and-develop-preclinical-candidates/ 2020-01-17T10:43:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/charles-river-lab.png http://www.pharmajournalist.com/bayer-and-wuxi-biologics-enter-into-an-agreement-on-a-leverkusen-drug-product-plant/ 2020-01-17T10:46:25+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/bayer.jpg http://www.pharmajournalist.com/alnylam-initiates-rolling-submission-of-nda-for-lumasiran-in-primary-hyperoxaluria-type-1/ 2020-01-17T10:49:46+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/alnylam-pharmaceuticals_logo.jpg http://www.pharmajournalist.com/sun-pharma-and-rockwell-medical-enter-into-licensing-agreement-for-triferic-in-india/ 2020-01-17T10:55:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/SunPharma.jpg http://www.pharmajournalist.com/demands-for-solutions-to-challenging-diseases-prompts-launch-of-azymus-therapeutics/ 2020-01-17T10:57:58+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/Azazymus-Therapeutics-Logo.jpg http://www.pharmajournalist.com/my-green-lab-announces-collaboration-with-astrazeneca/ 2020-01-17T11:01:20+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/Senior-Scientist-and-Green-Labs-team-member.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/01/Senior-Scientist-and-Green-Labs-team-member.jpg http://www.pharmajournalist.com/probiogen-and-lava-therapeutics-sign-cell-line-development-and-gmp-manufacturing-agreement-for-novel-bispecific-molecule/ 2020-01-17T11:02:42+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/ProBioGen-Logo.png http://www.pharmajournalist.com/asc-therapeutics-and-vigene-announce-long-term-strategic-partnership-for-gene-therapy-development-and-manufacturing/ 2020-01-17T11:07:52+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/ASC-Therapeutics-Logo.jpg http://www.pharmajournalist.com/focusing-on-cutting-edge-biopharmaceutical-technologies-boosting-the-industry-to-achieve-innovation-and-development-biolive-china-2020-is-ready/ 2020-01-21T08:53:23+00:00 http://www.pharmajournalist.com/wp-content/uploads/2020/01/31.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/01/32.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/01/33.jpg http://www.pharmajournalist.com/15-years-of-p-mec-china-driving-global-pharma-technology-forward-in-china/ 2020-01-21T09:22:30+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/43.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/01/41.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/01/42.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/01/43.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/01/44.jpg http://www.pharmajournalist.com/continuing-the-resplendence-with-20-years-glory-cphi-china-welcomes-the-golden-year-of-chinese-pharma/ 2020-01-21T09:23:55+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/12.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/01/11.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/01/12.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/01/13.jpg http://www.pharmajournalist.com/at-it-china-2020-to-be-held-alongside-cphi-p-mec-china-2020-will-showcase-intelligent-pharma-high-tech-solutions/ 2020-01-21T09:25:17+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/21.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/01/21.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/01/22.jpg http://www.pharmajournalist.com/hub-of-global-pharmaceutical-packaging-solutions-in-the-asia-pacific-region-innopack-china-gathering-innovative-forces/ 2020-01-21T09:32:03+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/53.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/01/51.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/01/52.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/01/53.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/01/54.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/01/55.png http://www.pharmajournalist.com/discover-the-latest-information-and-seize-market-opportunities-in-the-annual-event-of-the-cro-cmo-industry/ 2020-01-21T09:42:50+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/63-e1579599710925.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/01/61.jpg https://pharmajournalist.com/wp-content/uploads/2020/01/62.png http://www.pharmajournalist.com/wp-content/uploads/2020/01/63.jpg http://www.pharmajournalist.com/fdf-china-to-be-held-in-june-to-boost-chinese-pharmaceutical-enterprises-to-go-global-and-promote-the-innovation-and-development-of-industry/ 2020-01-21T09:46:35+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/71.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/01/71.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/01/72.jpg http://www.pharmajournalist.com/smis-pharmaceutical-microbiology-in-boston-what-to-expect-over-the-2-day-conference/ 2020-01-21T11:13:56+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/Brochure-Cover-Only-updated-Jan2020.png https://pharmajournalist.com/wp-content/uploads/2020/01/Brochure-Cover-Only-updated-Jan2020.png http://www.pharmajournalist.com/exclusive-speaker-interview-from-mrc-harwell-institute-released-4-weeks-ahead-of-smis-3d-cell-culture-conference/ 2020-01-23T09:08:32+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/1200x627-speaker-banner-Alex-Graham.jpg https://pharmajournalist.com/wp-content/uploads/2020/01/1200x627-speaker-banner-Alex-Graham.jpg http://www.pharmajournalist.com/moderna-announces-funding-award-from-cepi-to-accelerate-development-of-mrna-vaccine-against-novel-coronavirus/ 2020-01-24T10:49:59+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Moderna-Logo.png http://www.pharmajournalist.com/horizon-therapeutics-gets-fda-approval-for-thyroid-eye-disease-drug/ 2020-01-24T10:58:55+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/Horizon-Therapeutics-Logo.jpg http://www.pharmajournalist.com/novartis-announces-eu-approval-of-mayzent-siponimod-for-adult-patients-with-spms-with-active-disease/ 2020-01-24T11:03:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/imfinzi-and-tremelimumab-granted-orphan-drug-designation-in-the-us-for-liver-cancer/ 2020-01-24T11:05:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/gsk-fda-grants-priority-review-of-belantamab-mafodotin-for-patients-with-relapsed-or-refractory-multiple-myeloma/ 2020-01-24T11:08:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/gsk.jpg http://www.pharmajournalist.com/evotec-and-indivumed-announce-second-joint-drug-discovery-programme/ 2020-01-24T11:10:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/evotec.png http://www.pharmajournalist.com/inhibitor-therapeutics-receives-prostate-cancer-ind-clearance-from-fda/ 2020-01-24T11:14:08+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/INHIBITOR-Therapeutics.jpg http://www.pharmajournalist.com/genialis-and-oncologie-collaborate-on-precision-medicine-initiative-in-gastric-cancer/ 2020-01-24T11:16:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/drug.jpg http://www.pharmajournalist.com/hcats-and-ori-biotech-announce-a-joint-development-agreement/ 2020-01-24T11:21:10+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/Hitachi-Chemical-Logo.jpg http://www.pharmajournalist.com/sanofi-completes-acquisition-of-synthorx-inc/ 2020-01-24T11:25:41+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/bridge-biotherapeutics-announces-fda-ind-clearance-for-bbt-176-an-egfr-tki-for-nsclc/ 2020-01-24T11:27:34+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/bridegbio-therapeutics-logo.png http://www.pharmajournalist.com/mundipharma-enters-partnership-with-samsung-bioepis-to-expand-biosimilars-into-hong-kong-and-taiwan/ 2020-01-24T11:30:13+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Mundipharma-Logo.png http://www.pharmajournalist.com/epizyme-gets-fda-approval-for-tazverik-to-treat-epithelioid-sarcoma/ 2020-01-24T11:32:32+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/Epizyme-Logo.png http://www.pharmajournalist.com/european-commission-approves-roches-polivy-for-people-with-previously-treated-aggressive-lymphoma/ 2020-01-24T11:35:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/roches-risdiplam-meets-primary-endpoint-in-pivotal-firefish-trial-in-infants-with-type-1-spinal-muscular-atrophy/ 2020-01-24T11:38:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/fda-approves-first-treatment-for-thyroid-eye-disease/ 2020-01-24T11:43:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/calidi-biotherapeutics-secures-series-a-investments-to-advance-manufacturing/ 2020-01-24T11:44:54+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/Calidi_Biotherapeutics.jpg http://www.pharmajournalist.com/armas-pharmaceuticals-adds-four-generic-injectables-as-first-launches-of-2020/ 2020-01-24T11:49:21+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/Armas-Pharma-Logo.png http://www.pharmajournalist.com/catalent-biologics-supports-diamedicas-new-treatment-for-chronic-kidney-disease/ 2020-01-24T11:53:07+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Catalent-Logo.png http://www.pharmajournalist.com/bellicum-enters-into-asset-purchase-and-master-services-agreements-with-md-anderson/ 2020-01-24T11:57:53+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/Bellicum-Logo.png http://www.pharmajournalist.com/join-experts-within-supply-and-demand-at-europes-only-parallel-trade-conference-2020-in-london/ 2020-01-27T14:39:11+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Parallel-Trade-2020.jpg http://www.pharmajournalist.com/drug-product-formulation-and-control-strategies-discussed-at-pfs-east-coast/ 2020-01-28T11:28:09+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/Pre-filled-Syringes-East-Coast_Pharma-Journalist.jpg http://www.pharmajournalist.com/registration-opens-for-smis-20th-annual-pain-therapeutics-conference/ 2020-01-30T10:20:35+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Pain-Therapeutics-2020-Pharma-Journalist.jpg http://www.pharmajournalist.com/agenda-released-smithers-extractables-and-leachables-usa-2020-conference/ 2020-01-30T14:56:57+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/EL-USA-2020-Banner-Pharma-Journalist.jpg http://www.pharmajournalist.com/hear-updates-on-connected-drug-delivery-devices-at-injectable-drug-delivery-2020/ 2020-01-30T15:05:19+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/Injectable-drug-delivery.jpg http://www.pharmajournalist.com/sandoz-completes-acquisition-of-aspens-japanese-operations/ 2020-01-31T11:37:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/sandoz.jpg http://www.pharmajournalist.com/galapagos-orphan-drug-designation-for-glpg1690-in-systemic-sclerosis/ 2020-01-31T11:41:36+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/Galapagos-NV-Logo.png http://www.pharmajournalist.com/lilly-receives-fda-priority-review-for-the-selpercatinib-new-drug-application/ 2020-01-31T11:42:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/eyepoint-and-ocumension-sign-license-agreement-in-china-for-dexycu/ 2020-01-31T11:46:21+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/Eyepoint-Pharmaceuticals-Logo.png http://www.pharmajournalist.com/abbvie-and-allergan-announce-agreements-to-divest-brazikumab-and-zenpep/ 2020-01-31T11:48:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/allergan.jpg http://www.pharmajournalist.com/sanofi-fda-accepts-for-priority-review-dupixent-for-children/ 2020-01-31T11:51:59+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/fda-approves-mercks-dificid-fidaxomicin-to-treat-clostridioides-difficile-in-children-aged-six-months-and-older/ 2020-01-31T11:55:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/roche-submits-sbla-to-the-fda-for-tecentriq-in-combination-with-avastin-for-the-most-common-form-of-liver-cancer/ 2020-01-31T11:58:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/atai-life-sciences-announces-joint-venture-with-demerx-to-develop-ibogaine-for-opioid-use-disorder/ 2020-01-31T12:01:38+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/ATAI-Life-Sciences-Logo-1.png http://www.pharmajournalist.com/tilt-biotherapeutics-signs-a-licensing-deal-with-biotheus-for-cancer-therapy-with-oncolytic-virus-tilt-123/ 2020-01-31T12:04:30+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/TILT_logo.jpg http://www.pharmajournalist.com/alexion-completes-acquisition-of-achillion/ 2020-01-31T12:05:57+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Alexion-Pharma-Logo.png http://www.pharmajournalist.com/conatus-pharmaceuticals-and-histogen-enter-into-definitive-merger-agreement/ 2020-01-31T12:09:55+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/agex-therapeutics-enters-research-collaboration-with-japanese-biopharma-company-to-generate-hypoimmunogenic-cells/ 2020-01-31T12:15:25+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/Agex-Therapeutics-Logo.jpg http://www.pharmajournalist.com/wuxi-biologics-enables-development-of-multiple-neutralizing-antibodies-for-novel-coronavirus/ 2020-01-31T12:19:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/wuxi-biologics-logo.png http://www.pharmajournalist.com/inovio-collaborating-with-beijing-advaccine-to-advance-ino-4800-vaccine-against-new-coronavirus-in-china/ 2020-01-31T12:21:23+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/Inovia-Pharmaceuticals.jpg http://www.pharmajournalist.com/vasopharm-completes-patient-enrollment-for-phase-3-traumatic-brain-injury-trial-nostra/ 2020-01-31T12:24:30+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/vasopharm-logo.png http://www.pharmajournalist.com/johnson-johnson-launches-multi-pronged-response-to-coronavirus-global-public-health-threat/ 2020-01-31T12:27:04+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Johnson-Johnson-Logo.png http://www.pharmajournalist.com/accenture-and-google-cloud-collaborate-to-help-life-sciences-companies-advance-the-discovery-development-and-delivery-of-innovative-therapies/ 2020-01-31T12:34:50+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/accenture.jpg http://www.pharmajournalist.com/european-medicines-agency-validates-kites-marketing-application-for-companys-second-car-t-cell-therapy/ 2020-01-31T12:36:25+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Kite-Gilead-Company.png http://www.pharmajournalist.com/incyte-announces-that-the-true-ad2-pivotal-trial-of-ruxolitinib-cream-met-its-primary-endpoint-in-patients-with-atopic-dermatitis/ 2020-01-31T12:38:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/incyte-logo.jpg http://www.pharmajournalist.com/evotec-and-bayer-advance-further-programme-into-phase-i-clinical-development/ 2020-01-31T12:44:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/evotec.png http://www.pharmajournalist.com/pelican-biothermal-announces-expansion-of-distribution-into-australia-new-zealand/ 2020-01-31T12:49:46+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/wilpak_australia.jpg https://pharmajournalist.com/wp-content/uploads/2020/01/wilpak_australia.jpg http://www.pharmajournalist.com/lonza-supporting-rocket-pharma-with-clinical-manufacturing-of-rp-l201-for-the-treatment-of-leukocyte-adhesion-deficiency-i/ 2020-01-31T12:51:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/lonza.jpg http://www.pharmajournalist.com/vetter-aligns-its-development-service-laboratory-portfolio-under-one-roof/ 2020-01-31T12:53:14+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/Vetter-Pharma.jpg http://www.pharmajournalist.com/saga-diagnostics-extends-its-collaboration-with-servier-to-use-ultrasensitive-sagasafe-technology-in-cancer-clinical-trials/ 2020-01-31T13:07:55+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/Saga-Diagnostics-Logo.jpg http://www.pharmajournalist.com/bionetix-proqinase-and-mercachemsyncom-announce-a-joint-research-project-from-target-identification-to-clinical-study/ 2020-01-31T13:11:08+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/ProQinase-Logo.png http://www.pharmajournalist.com/sae-international-expands-global-footprint-with-acquisition-of-smi-group-ltd/ 2020-02-05T07:26:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/SMi-Group-Ltd-Logo.png http://www.pharmajournalist.com/assertio-therapeutics-announces-sale-of-nucynta-franchise-to-collegium-pharmaceutical-for-375-0-million/ 2020-02-07T10:12:37+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/Assertio-Logo.png http://www.pharmajournalist.com/aimmune-therapeutics-announces-additional-200-million-equity-investment-by-nestle-health-science/ 2020-02-07T10:14:14+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Aimmune-Therapeutics-logo.png http://www.pharmajournalist.com/boehringer-ingelheim-receives-approval-for-aservo-equihaler-industry-first-therapy-for-severe-equine-asthma/ 2020-02-07T10:17:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Boehringer-Ingelheim.jpg http://www.pharmajournalist.com/regeneron-announces-expanded-collaboration-with-hhs-to-develop-antibody-treatments-for-new-coronavirus/ 2020-02-07T10:18:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/regeneron.jpg http://www.pharmajournalist.com/biomotiv-and-bristol-myers-squibb-announce-the-launch-of-anteros-pharmaceuticals/ 2020-02-07T10:20:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/emory-collaborators-testing-antiviral-drug-as-potential-treatment-for-coronaviruses/ 2020-02-07T10:23:14+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/story_main.png https://pharmajournalist.com/wp-content/uploads/2020/02/story_main.png http://www.pharmajournalist.com/seqirus-announces-fda-approval-of-its-first-ever-adjuvanted-cell-based-pandemic-influenza-a-h5n1-vaccine/ 2020-02-07T10:26:30+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/Sequirus.jpg http://www.pharmajournalist.com/catalent-to-acquire-leading-cell-therapy-company-masthercell-global-for-315-million/ 2020-02-07T10:32:45+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Catalent-Logo.png http://www.pharmajournalist.com/wpd-pharma-completed-the-acquisition-of-two-pancreatic-cancer-drug-candidates/ 2020-02-07T10:36:58+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/WPD-Pharma-Logo.gif http://www.pharmajournalist.com/geneyork-pharmaceutical-announces-u-s-launch-of-generic-version-of-deltasone-prednisone-tablets/ 2020-02-07T10:39:27+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/Geneyork-logo.jpg http://www.pharmajournalist.com/avacta-and-daewoong-agree-collaboration-and-license-agreement-with-affyxell-therapeutics/ 2020-02-07T10:41:46+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/Avacta.jpg http://www.pharmajournalist.com/applied-biomath-llc-announces-collaboration-with-gritstone-oncology/ 2020-02-07T10:43:54+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/applied-biomath-logo.png http://www.pharmajournalist.com/betterlife-pharma-acquires-swiss-based-solmic-ag/ 2020-02-07T10:45:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/navrogen-and-levena-announce-collaboration-to-develop-adcs-to-treat-humoral-immuno-suppressed-cancers/ 2020-02-07T10:48:14+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/navrogen-logo.jpg http://www.pharmajournalist.com/realta-life-sciences-announces-fda-orphan-drug-designation-for-pic1-for-the-treatment-of-hypoxic-ischemic-encephalopathy/ 2020-02-07T10:51:22+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/realta-logo.jpg http://www.pharmajournalist.com/rebiotix-a-ferring-company-completes-enrollment-for-first-ever-pivotal-phase-3-clinical-trial-of-microbiota-based-rbx2660/ 2020-02-07T10:54:28+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/Rebiotix-Logo.jpg http://www.pharmajournalist.com/immix-doses-first-patient-in-usa-in-its-phase-1b-2a-trial-in-patients-with-advanced-solid-tumors/ 2020-02-07T10:57:54+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/immix-biopharma.png http://www.pharmajournalist.com/merck-gets-fda-priority-review-for-recarbrio-in-habp-vabp/ 2020-02-07T11:00:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/teva-announces-positive-top-line-results-from-ajovy-fremanezumab-clinical-trials-in-japan/ 2020-02-07T11:04:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/TEVA-Pharma.jpg http://www.pharmajournalist.com/stevanato-group-signs-an-agreement-with-pfeiffer-vacuum/ 2020-02-07T11:07:24+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/SG-Stevanato-Group-Logo.png http://www.pharmajournalist.com/acg-inspection-introduces-groundbreaking-blockchain-based-brand-platform/ 2020-02-07T11:20:51+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/ACG-Inspection.jpg https://pharmajournalist.com/wp-content/uploads/2020/02/ACG-Inspection.jpg http://www.pharmajournalist.com/cns-pharmaceuticals-completes-pilot-manufacturing-steps-pursuant-to-fda-pre-ind-guidance/ 2020-02-07T11:25:07+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/CNS-Pharma-Logo.jpg http://www.pharmajournalist.com/lsne-expands-vial-filling-and-lyophilization-capacity-with-isolator-technology/ 2020-02-07T11:28:09+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/LSNE.jpg http://www.pharmajournalist.com/stevanato-group-bormioli-pharma-partner-on-ez-fill-packaging/ 2020-02-07T11:30:10+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/Stevanato-Group.jpg http://www.pharmajournalist.com/pelican-biothermal-announces-acquisition-of-nanocool/ 2020-02-07T11:33:06+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/ACQUISITION-OF-NANOCOOL.jpg https://pharmajournalist.com/wp-content/uploads/2020/02/ACQUISITION-OF-NANOCOOL.jpg http://www.pharmajournalist.com/pfizer-receives-positive-chmp-opinion-for-oncology-biosimilar-ruxience-rituximab/ 2020-02-07T11:39:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/invora-herbicide-receives-epa-federal-approval/ 2020-02-07T11:43:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/bayer.jpg http://www.pharmajournalist.com/hpapi-2020-conference-to-discuss-containment-solutions-and-adc-developments/ 2020-02-10T08:24:21+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/HPAPI-London-Pharma-Journalist-Banner.jpg http://www.pharmajournalist.com/60-organizations-to-speak-as-the-nash-summit-boston-returns/ 2020-02-10T13:46:41+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/Nash-Banner-ad-250x300-v2.gif http://www.pharmajournalist.com/showcase-your-ras-research-to-80-industry-leaders-deadline-approaching/ 2020-02-10T15:05:57+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/RAS-EU-Pharma-Journalist-Banner.png http://www.pharmajournalist.com/ai-in-drug-discovery-to-host-panel-discussion-on-the-ai-paradigm-shift-is-it-just-a-hype/ 2020-02-11T08:20:35+00:00 https://pharmajournalist.com/wp-content/uploads/2019/11/AI-Drug-Discovery.jpg http://www.pharmajournalist.com/conference-chair-from-astrazeneca-invites-you-to-attend-pre-filled-syringes-east-coast-2020/ 2020-02-12T11:32:27+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/Pre-filled-Syringes-East-Coast_Pharma-Journalist.jpg http://www.pharmajournalist.com/fda-grants-priority-review-for-kites-kte-x19-bla-in-relapsed-or-refractory-mantle-cell-lymphoma/ 2020-02-14T11:05:25+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/ose-immunotherapeutics-announces-artificial-intelligence-antibody-drug-development-collaboration-with-mabsilico/ 2020-02-14T11:09:09+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/OSE-Immunotherapeutics-Logo.jpg http://www.pharmajournalist.com/vir-biotechnology-identifies-two-antibodies-that-bind-to-the-spike-protein-of-2019-ncov-newly-named-as-sars-cov-2/ 2020-02-14T11:15:21+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/VIR-Logo.jpg http://www.pharmajournalist.com/bayer-and-nuvisan-create-new-research-unit-in-berlin/ 2020-02-14T11:16:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/bayer.jpg